   test:1635990410
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636096227
   {
     "error": "invalid request",
     "code": 400
   }






   ##########
   test:1636096308
   {
     "usage": {
       "text_units": 1,
       "text_characters": 2507,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.754178,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "spinoff of Kyndryl"
         },
         "sentence": "From the acquisition of Red Hat to this week’s spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble",
         "action": {
           "verb": {
             "text": "has",
             "tense": "present"
           },
           "text": "s",
           "normalized": "s"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": "From the acquisition of Red Hat to this week’s spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble",
         "object": {
           "text": "taken decisive actions"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": "From the acquisition of Red Hat to this week’s spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble",
         "object": {
           "text": "decisive actions to become more strategic"
         },
         "action": {
           "verb": {
             "text": "take",
             "tense": "past"
           },
           "text": "has taken",
           "normalized": "have take"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": "From the acquisition of Red Hat to this week’s spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble",
         "object": {
           "text": "more strategic"
         },
         "action": {
           "verb": {
             "text": "become",
             "tense": "future"
           },
           "text": "to become",
           "normalized": "to become"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "action": {
           "verb": {
             "text": "believe",
             "tense": "past"
           },
           "text": "believed",
           "normalized": "believe"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "object": {
           "text": "innovation"
         },
         "action": {
           "verb": {
             "text": "apply",
             "tense": "present"
           },
           "text": "apply",
           "normalized": "apply"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "object": {
           "text": "progress"
         },
         "action": {
           "verb": {
             "text": "drive",
             "tense": "present"
           },
           "text": "drive",
           "normalized": "drive"
         }
       },
       {
         "subject": {
           "text": "the nature of those problems"
         },
         "sentence": " And as the nature of those problems has changed over time, so too has IBM, repeatedly reinventing itself to overcome whatever obstacles stand in the way of that progress.",
         "object": {
           "text": "changed over time"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "the nature of those problems"
         },
         "sentence": " And as the nature of those problems has changed over time, so too has IBM, repeatedly reinventing itself to overcome whatever obstacles stand in the way of that progress.",
         "action": {
           "verb": {
             "text": "change",
             "tense": "past"
           },
           "text": "has changed",
           "normalized": "have change"
         }
       },
       {
         "subject": {
           "text": "itself"
         },
         "sentence": " And as the nature of those problems has changed over time, so too has IBM, repeatedly reinventing itself to overcome whatever obstacles stand in the way of that progress.",
         "action": {
           "verb": {
             "text": "reinvent",
             "tense": "present"
           },
           "text": "reinventing",
           "normalized": "reinvent"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " Though we’ve introduced many foundational technologies, IBM has never been defined solely by its products or services.",
         "object": {
           "text": "introduced many foundational technologies"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "have",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " Though we’ve introduced many foundational technologies, IBM has never been defined solely by its products or services.",
         "object": {
           "text": "many foundational technologies"
         },
         "action": {
           "verb": {
             "text": "introduce",
             "tense": "past"
           },
           "text": "ve introduced",
           "normalized": "ve introduce"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " Though we’ve introduced many foundational technologies, IBM has never been defined solely by its products or services.",
         "object": {
           "text": "never been defined solely by its products or services"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " Though we’ve introduced many foundational technologies, IBM has never been defined solely by its products or services.",
         "object": {
           "text": "by its products or services"
         },
         "action": {
           "verb": {
             "text": "define",
             "tense": "past"
           },
           "text": "defined",
           "normalized": "define"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " Rather, IBM’s most enduring characteristic is our ability to change to deliver value to our clients, while remaining true to the core values that guide us.",
         "object": {
           "text": "most enduring characteristic is our ability to change to deliver value to our clients"
         },
         "action": {
           "verb": {
             "text": "has",
             "tense": "present"
           },
           "text": "s",
           "normalized": "s"
         }
       },
       {
         "subject": {
           "text": "IBM’s most enduring characteristic"
         },
         "sentence": " Rather, IBM’s most enduring characteristic is our ability to change to deliver value to our clients, while remaining true to the core values that guide us.",
         "object": {
           "text": "our ability to change to deliver value to our clients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "value"
         },
         "sentence": " Rather, IBM’s most enduring characteristic is our ability to change to deliver value to our clients, while remaining true to the core values that guide us.",
         "object": {
           "text": "to our clients"
         },
         "action": {
           "verb": {
             "text": "deliver",
             "tense": "future"
           },
           "text": "to change to deliver",
           "normalized": "to change to deliver"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday’s spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "object": {
           "text": "taken decisive strategic actions"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday’s spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "object": {
           "text": "decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday’s spinoff of our managed infrastructure services business, now known as Kyndryl"
         },
         "action": {
           "verb": {
             "text": "take",
             "tense": "past"
           },
           "text": "has taken",
           "normalized": "have take"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday’s spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "object": {
           "text": "the unique needs of this moment"
         },
         "action": {
           "verb": {
             "text": "meet",
             "tense": "future"
           },
           "text": "to meet",
           "normalized": "to meet"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " To do this, we have:",
         "object": {
           "text": "this"
         },
         "action": {
           "verb": {
             "text": "do",
             "tense": "future"
           },
           "text": "To do",
           "normalized": "To do"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " As always, we remain dedicated to our clients’ success, we pursue innovation that matters, and we set the standard for trust and responsibility.",
         "action": {
           "verb": {
             "text": "remain",
             "tense": "present"
           },
           "text": "remain",
           "normalized": "remain"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " As always, we remain dedicated to our clients’ success, we pursue innovation that matters, and we set the standard for trust and responsibility.",
         "object": {
           "text": "to our clients’ success, we pursue innovation that matters, and we set the standard for trust and responsibility"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " But IBM is now more strategically focused, more technologically capable, more committed to equity, inclusion and sustainability, and more financially sound.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " But IBM is now more strategically focused, more technologically capable, more committed to equity, inclusion and sustainability, and more financially sound.",
         "object": {
           "text": "more technologically capable, more committed to equity, inclusion and sustainability, and more financially sound"
         },
         "action": {
           "verb": {
             "text": "focus",
             "tense": "past"
           },
           "text": "focused",
           "normalized": "focus"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are better able to integrate technology and expertise to solve our clients’ problems, regardless of whether the solutions come from IBM, our business partners, or even our competitors.",
         "object": {
           "text": "technology and expertise"
         },
         "action": {
           "verb": {
             "text": "integrate",
             "tense": "future"
           },
           "text": "to integrate",
           "normalized": "to integrate"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are better able to integrate technology and expertise to solve our clients’ problems, regardless of whether the solutions come from IBM, our business partners, or even our competitors.",
         "object": {
           "text": "our clients’ problems"
         },
         "action": {
           "verb": {
             "text": "solve",
             "tense": "future"
           },
           "text": "to solve",
           "normalized": "to solve"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM’s clients own and operate the most mission-critical systems on the planet: electrical grids, airlines, mobile networks, banks, and many others.",
         "object": {
           "text": "clients own"
         },
         "action": {
           "verb": {
             "text": "has",
             "tense": "present"
           },
           "text": "s",
           "normalized": "s"
         }
       },
       {
         "subject": {
           "text": "IBM’s clients"
         },
         "sentence": " IBM’s clients own and operate the most mission-critical systems on the planet: electrical grids, airlines, mobile networks, banks, and many others.",
         "object": {
           "text": "electrical grids, airlines, mobile networks, banks, and many others"
         },
         "action": {
           "verb": {
             "text": "own",
             "tense": "present"
           },
           "text": "own and operate",
           "normalized": "own and operate"
         }
       },
       {
         "subject": {
           "text": "IBM’s clients"
         },
         "sentence": " IBM’s clients own and operate the most mission-critical systems on the planet: electrical grids, airlines, mobile networks, banks, and many others.",
         "object": {
           "text": "the most mission-critical systems"
         },
         "action": {
           "verb": {
             "text": "operate",
             "tense": "present"
           },
           "text": "own and operate",
           "normalized": "own and operate"
         }
       },
       {
         "subject": {
           "text": "These systems"
         },
         "sentence": " These systems are more than just engines of economic growth.",
         "object": {
           "text": "more than just engines of economic growth"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the systems"
         },
         "sentence": " They are the systems that support modern society.",
         "object": {
           "text": "modern society"
         },
         "action": {
           "verb": {
             "text": "support",
             "tense": "present"
           },
           "text": "support",
           "normalized": "support"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "them"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "n’t"
         },
         "action": {
           "verb": {
             "text": "do",
             "tense": "present"
           },
           "text": "do",
           "normalized": "do"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "just make business work"
         },
         "action": {
           "verb": {
             "text": "n’t",
             "tense": "present"
           },
           "text": "don’t",
           "normalized": "don’t"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "business work"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "make",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "the world"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "make",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We don’t just drive business value, we drive progress.",
         "object": {
           "text": "n’t just drive business value"
         },
         "action": {
           "verb": {
             "text": "do",
             "tense": "present"
           },
           "text": "do",
           "normalized": "do"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We don’t just drive business value, we drive progress.",
         "object": {
           "text": "just drive business value"
         },
         "action": {
           "verb": {
             "text": "n’t",
             "tense": "present"
           },
           "text": "don’t",
           "normalized": "don’t"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " We don’t just drive business value, we drive progress.",
         "object": {
           "text": "progress"
         },
         "action": {
           "verb": {
             "text": "drive",
             "tense": "present"
           },
           "text": "drive",
           "normalized": "drive"
         }
       },
       {
         "subject": {
           "text": "I"
         },
         "sentence": " I believe IBM is uniquely suited to be the catalyst of that progress for decades to come.",
         "object": {
           "text": "IBM is uniquely suited to be the catalyst of that progress for decades to come"
         },
         "action": {
           "verb": {
             "text": "believe",
             "tense": "present"
           },
           "text": "believe",
           "normalized": "believe"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " I believe IBM is uniquely suited to be the catalyst of that progress for decades to come.",
         "object": {
           "text": "to be the catalyst of that progress for decades to come"
         },
         "action": {
           "verb": {
             "text": "suit",
             "tense": "past"
           },
           "text": "suited",
           "normalized": "suit"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This is today’s IBM.",
         "object": {
           "text": "today’s IBM"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "data"
         },
         "sentence": " Prolifics developed its flexible Quick FHIR solution to rapidly standardize disparate health record formats, securely share data within a system, and reveal trends and predictors from patient histories",
         "object": {
           "text": "within a system, and reveal trends and predictors from patient histories"
         },
         "action": {
           "verb": {
             "text": "share",
             "tense": "present"
           },
           "text": "share",
           "normalized": "share"
         }
       },
       {
         "subject": {
           "text": "Prolifics"
         },
         "sentence": " Prolifics developed its flexible Quick FHIR solution to rapidly standardize disparate health record formats, securely share data within a system, and reveal trends and predictors from patient histories",
         "object": {
           "text": "trends and predictors from patient histories"
         },
         "action": {
           "verb": {
             "text": "reveal",
             "tense": "present"
           },
           "text": "reveal",
           "normalized": "reveal"
         }
       }
     ],
     "retrieved_url": "https://www.ibm.com/us-en/?ar=1",
     "relations": [
       {
         "type": "timeOf",
         "sentence": "From the acquisition of Red Hat to this week's spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "score": 0.84624,
         "arguments": [
           {
             "text": "this week",
             "location": [
               35,
               44
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "this week"
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               9,
               20
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "basedIn",
         "sentence": "From the acquisition of Red Hat to this week's spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "score": 0.56273,
         "arguments": [
           {
             "text": "IBM",
             "location": [
               67,
               70
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "Kyndryl",
             "location": [
               58,
               65
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Kyndryl"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday's spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "score": 0.546185,
         "arguments": [
           {
             "text": "IBM",
             "location": [
               760,
               763
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               856,
               867
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday's spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "score": 0.468712,
         "arguments": [
           {
             "text": "our",
             "location": [
               852,
               855
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "them"
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               856,
               867
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday's spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "score": 0.862317,
         "arguments": [
           {
             "text": "2019",
             "location": [
               882,
               886
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "2019"
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               856,
               867
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday's spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "score": 0.46787,
         "arguments": [
           {
             "text": "yesterday",
             "location": [
               891,
               900
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "yesterday"
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               856,
               867
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "To do this, we have: Refocused our company around two primary sources of client value: technology and business expertise.",
         "score": 0.328285,
         "arguments": [
           {
             "text": "our",
             "location": [
               1170,
               1173
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "them"
               }
             ]
           },
           {
             "text": "company",
             "location": [
               1174,
               1181
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "company"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "We are better able to integrate technology and expertise to solve our clients' problems, regardless of whether the solutions come from IBM, our business partners, or even our competitors.",
         "score": 0.509207,
         "arguments": [
           {
             "text": "partners",
             "location": [
               1716,
               1724
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "partners"
               }
             ]
           },
           {
             "text": "our",
             "location": [
               1703,
               1706
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "employedBy",
         "sentence": "IBM's clients own and operate the most mission-critical systems on the planet: electrical grids, airlines, mobile networks, banks, and many others.",
         "score": 0.538102,
         "arguments": [
           {
             "text": "clients",
             "location": [
               1757,
               1764
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clients"
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               1751,
               1754
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "IBM Logo",
       "publication_date": "2021-11-04T00:00:00",
       "image": "",
       "feeds": [],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "acquisition of Red Hat",
         "relevance": 0.649907,
         "count": 2
       },
       {
         "text": "decisive actions",
         "relevance": 0.614996,
         "count": 1
       },
       {
         "text": "unique needs of this moment",
         "relevance": 0.614275,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.600406,
         "count": 8
       },
       {
         "text": "fundamental promise of technology",
         "relevance": 0.59605,
         "count": 1
       },
       {
         "text": "real-world problems",
         "relevance": 0.593631,
         "count": 1
       },
       {
         "text": "week’s spinoff",
         "relevance": 0.580508,
         "count": 1
       },
       {
         "text": "decisive strategic actions",
         "relevance": 0.578441,
         "count": 1
       },
       {
         "text": "primary sources of client value",
         "relevance": 0.576429,
         "count": 1
       },
       {
         "text": "flexible Quick FHIR solution",
         "relevance": 0.559928,
         "count": 1
       },
       {
         "text": "mission-critical systems",
         "relevance": 0.556944,
         "count": 1
       },
       {
         "text": "disparate health record formats",
         "relevance": 0.548502,
         "count": 1
       },
       {
         "text": "mobile networks",
         "relevance": 0.547862,
         "count": 1
       },
       {
         "text": "nature of those problems",
         "relevance": 0.547704,
         "count": 1
       },
       {
         "text": "core values",
         "relevance": 0.54094,
         "count": 1
       },
       {
         "text": "clients",
         "relevance": 0.539836,
         "count": 1
       },
       {
         "text": "foundational technologies",
         "relevance": 0.538452,
         "count": 1
       },
       {
         "text": "IBM’s clients",
         "relevance": 0.534676,
         "count": 1
       },
       {
         "text": "clients’ success",
         "relevance": 0.533768,
         "count": 1
       },
       {
         "text": "clients’ problems",
         "relevance": 0.524586,
         "count": 1
       },
       {
         "text": "goal",
         "relevance": 0.524118,
         "count": 1
       },
       {
         "text": "business partners",
         "relevance": 0.523463,
         "count": 1
       },
       {
         "text": "yesterday’s spinoff",
         "relevance": 0.520431,
         "count": 1
       },
       {
         "text": "today’s IBM",
         "relevance": 0.520217,
         "count": 1
       },
       {
         "text": "business expertise",
         "relevance": 0.518994,
         "count": 1
       },
       {
         "text": "electrical grids",
         "relevance": 0.518439,
         "count": 1
       },
       {
         "text": "common barriers",
         "relevance": 0.517244,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.517065,
         "count": 1
       },
       {
         "text": "innovation",
         "relevance": 0.516382,
         "count": 3
       },
       {
         "text": "business",
         "relevance": 0.515292,
         "count": 1
       },
       {
         "text": "value",
         "relevance": 0.514726,
         "count": 1
       },
       {
         "text": "modern society",
         "relevance": 0.513796,
         "count": 1
       },
       {
         "text": "today",
         "relevance": 0.513157,
         "count": 1
       },
       {
         "text": "company",
         "relevance": 0.511168,
         "count": 1
       },
       {
         "text": "ability",
         "relevance": 0.5107,
         "count": 1
       },
       {
         "text": "infrastructure services business",
         "relevance": 0.510211,
         "count": 1
       },
       {
         "text": "planet",
         "relevance": 0.509161,
         "count": 1
       },
       {
         "text": "airlines",
         "relevance": 0.508503,
         "count": 1
       },
       {
         "text": "business work",
         "relevance": 0.507393,
         "count": 1
       },
       {
         "text": "proprietary technologies",
         "relevance": 0.507105,
         "count": 1
       },
       {
         "text": "data",
         "relevance": 0.506771,
         "count": 1
       },
       {
         "text": "technology",
         "relevance": 0.506249,
         "count": 2
       },
       {
         "text": "services",
         "relevance": 0.505455,
         "count": 1
       },
       {
         "text": "expertise",
         "relevance": 0.505362,
         "count": 1
       },
       {
         "text": "banks",
         "relevance": 0.505038,
         "count": 1
       },
       {
         "text": "matters",
         "relevance": 0.504858,
         "count": 1
       },
       {
         "text": "progress",
         "relevance": 0.504742,
         "count": 2
       },
       {
         "text": "equity",
         "relevance": 0.504007,
         "count": 1
       },
       {
         "text": "trends",
         "relevance": 0.504007,
         "count": 1
       },
       {
         "text": "obstacles",
         "relevance": 0.503675,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.981358,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 11,
         "confidence": 1
       },
       {
         "type": "Organization",
         "text": "Kyndryl",
         "relevance": 0.716711,
         "count": 2,
         "confidence": 0.928104
       },
       {
         "type": "Organization",
         "text": "Red Hat",
         "relevance": 0.170142,
         "disambiguation": {
           "subtype": [
             "Company",
             "SoftwareDeveloper",
             "VentureFundedCompany",
             "VideoGamePublisher"
           ],
           "name": "Red_Hat",
           "dbpedia_resource": "http://dbpedia.org/resource/Red_Hat"
         },
         "count": 1,
         "confidence": 0.699293
       },
       {
         "type": "Organization",
         "text": "Prolifics",
         "relevance": 0.044968,
         "count": 1,
         "confidence": 0.901254
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.106702,
           "joy": 0.6178,
           "fear": 0.05546,
           "disgust": 0.028805,
           "anger": 0.09705
         }
       }
     },
     "concepts": [
       {
         "text": "Technology",
         "relevance": 0.948274,
         "dbpedia_resource": "http://dbpedia.org/resource/Technology"
       },
       {
         "text": "Economic growth",
         "relevance": 0.617515,
         "dbpedia_resource": "http://dbpedia.org/resource/Economic_growth"
       },
       {
         "text": "Sociology",
         "relevance": 0.573641,
         "dbpedia_resource": "http://dbpedia.org/resource/Sociology"
       },
       {
         "text": "2002 albums",
         "relevance": 0.527353,
         "dbpedia_resource": "http://dbpedia.org/resource/2002_albums"
       },
       {
         "text": "System",
         "relevance": 0.507223,
         "dbpedia_resource": "http://dbpedia.org/resource/System"
       },
       {
         "text": "Innovation",
         "relevance": 0.493967,
         "dbpedia_resource": "http://dbpedia.org/resource/Innovation"
       },
       {
         "text": "Linux",
         "relevance": 0.485822,
         "dbpedia_resource": "http://dbpedia.org/resource/Linux"
       },
       {
         "text": "Corporation",
         "relevance": 0.485235,
         "dbpedia_resource": "http://dbpedia.org/resource/Corporation"
       }
     ],
     "categories": [
       {
         "score": 0.907615,
         "label": "/business and industrial/business software"
       },
       {
         "score": 0.899929,
         "label": "/technology and computing"
       },
       {
         "score": 0.898749,
         "label": "/business and industrial/business operations/management/business process"
       }
     ]
   }






   ##########
   test:1636096351
   {
     "usage": {
       "text_units": 1,
       "text_characters": 2507,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.754178,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "spinoff of Kyndryl"
         },
         "sentence": "From the acquisition of Red Hat to this week’s spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble",
         "action": {
           "verb": {
             "text": "has",
             "tense": "present"
           },
           "text": "s",
           "normalized": "s"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": "From the acquisition of Red Hat to this week’s spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble",
         "object": {
           "text": "taken decisive actions"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": "From the acquisition of Red Hat to this week’s spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble",
         "object": {
           "text": "decisive actions to become more strategic"
         },
         "action": {
           "verb": {
             "text": "take",
             "tense": "past"
           },
           "text": "has taken",
           "normalized": "have take"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": "From the acquisition of Red Hat to this week’s spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble",
         "object": {
           "text": "more strategic"
         },
         "action": {
           "verb": {
             "text": "become",
             "tense": "future"
           },
           "text": "to become",
           "normalized": "to become"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "action": {
           "verb": {
             "text": "believe",
             "tense": "past"
           },
           "text": "believed",
           "normalized": "believe"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "object": {
           "text": "innovation"
         },
         "action": {
           "verb": {
             "text": "apply",
             "tense": "present"
           },
           "text": "apply",
           "normalized": "apply"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "object": {
           "text": "progress"
         },
         "action": {
           "verb": {
             "text": "drive",
             "tense": "present"
           },
           "text": "drive",
           "normalized": "drive"
         }
       },
       {
         "subject": {
           "text": "the nature of those problems"
         },
         "sentence": " And as the nature of those problems has changed over time, so too has IBM, repeatedly reinventing itself to overcome whatever obstacles stand in the way of that progress.",
         "object": {
           "text": "changed over time"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "the nature of those problems"
         },
         "sentence": " And as the nature of those problems has changed over time, so too has IBM, repeatedly reinventing itself to overcome whatever obstacles stand in the way of that progress.",
         "action": {
           "verb": {
             "text": "change",
             "tense": "past"
           },
           "text": "has changed",
           "normalized": "have change"
         }
       },
       {
         "subject": {
           "text": "itself"
         },
         "sentence": " And as the nature of those problems has changed over time, so too has IBM, repeatedly reinventing itself to overcome whatever obstacles stand in the way of that progress.",
         "action": {
           "verb": {
             "text": "reinvent",
             "tense": "present"
           },
           "text": "reinventing",
           "normalized": "reinvent"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " Though we’ve introduced many foundational technologies, IBM has never been defined solely by its products or services.",
         "object": {
           "text": "introduced many foundational technologies"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "have",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " Though we’ve introduced many foundational technologies, IBM has never been defined solely by its products or services.",
         "object": {
           "text": "many foundational technologies"
         },
         "action": {
           "verb": {
             "text": "introduce",
             "tense": "past"
           },
           "text": "ve introduced",
           "normalized": "ve introduce"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " Though we’ve introduced many foundational technologies, IBM has never been defined solely by its products or services.",
         "object": {
           "text": "never been defined solely by its products or services"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " Though we’ve introduced many foundational technologies, IBM has never been defined solely by its products or services.",
         "object": {
           "text": "by its products or services"
         },
         "action": {
           "verb": {
             "text": "define",
             "tense": "past"
           },
           "text": "defined",
           "normalized": "define"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " Rather, IBM’s most enduring characteristic is our ability to change to deliver value to our clients, while remaining true to the core values that guide us.",
         "object": {
           "text": "most enduring characteristic is our ability to change to deliver value to our clients"
         },
         "action": {
           "verb": {
             "text": "has",
             "tense": "present"
           },
           "text": "s",
           "normalized": "s"
         }
       },
       {
         "subject": {
           "text": "IBM’s most enduring characteristic"
         },
         "sentence": " Rather, IBM’s most enduring characteristic is our ability to change to deliver value to our clients, while remaining true to the core values that guide us.",
         "object": {
           "text": "our ability to change to deliver value to our clients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "value"
         },
         "sentence": " Rather, IBM’s most enduring characteristic is our ability to change to deliver value to our clients, while remaining true to the core values that guide us.",
         "object": {
           "text": "to our clients"
         },
         "action": {
           "verb": {
             "text": "deliver",
             "tense": "future"
           },
           "text": "to change to deliver",
           "normalized": "to change to deliver"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday’s spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "object": {
           "text": "taken decisive strategic actions"
         },
         "action": {
           "verb": {
             "text": "have",
             "tense": "present"
           },
           "text": "has",
           "normalized": "have"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday’s spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "object": {
           "text": "decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday’s spinoff of our managed infrastructure services business, now known as Kyndryl"
         },
         "action": {
           "verb": {
             "text": "take",
             "tense": "past"
           },
           "text": "has taken",
           "normalized": "have take"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday’s spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "object": {
           "text": "the unique needs of this moment"
         },
         "action": {
           "verb": {
             "text": "meet",
             "tense": "future"
           },
           "text": "to meet",
           "normalized": "to meet"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " To do this, we have:",
         "object": {
           "text": "this"
         },
         "action": {
           "verb": {
             "text": "do",
             "tense": "future"
           },
           "text": "To do",
           "normalized": "To do"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " As always, we remain dedicated to our clients’ success, we pursue innovation that matters, and we set the standard for trust and responsibility.",
         "action": {
           "verb": {
             "text": "remain",
             "tense": "present"
           },
           "text": "remain",
           "normalized": "remain"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " As always, we remain dedicated to our clients’ success, we pursue innovation that matters, and we set the standard for trust and responsibility.",
         "object": {
           "text": "to our clients’ success, we pursue innovation that matters, and we set the standard for trust and responsibility"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " But IBM is now more strategically focused, more technologically capable, more committed to equity, inclusion and sustainability, and more financially sound.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " But IBM is now more strategically focused, more technologically capable, more committed to equity, inclusion and sustainability, and more financially sound.",
         "object": {
           "text": "more technologically capable, more committed to equity, inclusion and sustainability, and more financially sound"
         },
         "action": {
           "verb": {
             "text": "focus",
             "tense": "past"
           },
           "text": "focused",
           "normalized": "focus"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are better able to integrate technology and expertise to solve our clients’ problems, regardless of whether the solutions come from IBM, our business partners, or even our competitors.",
         "object": {
           "text": "technology and expertise"
         },
         "action": {
           "verb": {
             "text": "integrate",
             "tense": "future"
           },
           "text": "to integrate",
           "normalized": "to integrate"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are better able to integrate technology and expertise to solve our clients’ problems, regardless of whether the solutions come from IBM, our business partners, or even our competitors.",
         "object": {
           "text": "our clients’ problems"
         },
         "action": {
           "verb": {
             "text": "solve",
             "tense": "future"
           },
           "text": "to solve",
           "normalized": "to solve"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " IBM’s clients own and operate the most mission-critical systems on the planet: electrical grids, airlines, mobile networks, banks, and many others.",
         "object": {
           "text": "clients own"
         },
         "action": {
           "verb": {
             "text": "has",
             "tense": "present"
           },
           "text": "s",
           "normalized": "s"
         }
       },
       {
         "subject": {
           "text": "IBM’s clients"
         },
         "sentence": " IBM’s clients own and operate the most mission-critical systems on the planet: electrical grids, airlines, mobile networks, banks, and many others.",
         "object": {
           "text": "electrical grids, airlines, mobile networks, banks, and many others"
         },
         "action": {
           "verb": {
             "text": "own",
             "tense": "present"
           },
           "text": "own and operate",
           "normalized": "own and operate"
         }
       },
       {
         "subject": {
           "text": "IBM’s clients"
         },
         "sentence": " IBM’s clients own and operate the most mission-critical systems on the planet: electrical grids, airlines, mobile networks, banks, and many others.",
         "object": {
           "text": "the most mission-critical systems"
         },
         "action": {
           "verb": {
             "text": "operate",
             "tense": "present"
           },
           "text": "own and operate",
           "normalized": "own and operate"
         }
       },
       {
         "subject": {
           "text": "These systems"
         },
         "sentence": " These systems are more than just engines of economic growth.",
         "object": {
           "text": "more than just engines of economic growth"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the systems"
         },
         "sentence": " They are the systems that support modern society.",
         "object": {
           "text": "modern society"
         },
         "action": {
           "verb": {
             "text": "support",
             "tense": "present"
           },
           "text": "support",
           "normalized": "support"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "them"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "n’t"
         },
         "action": {
           "verb": {
             "text": "do",
             "tense": "present"
           },
           "text": "do",
           "normalized": "do"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "just make business work"
         },
         "action": {
           "verb": {
             "text": "n’t",
             "tense": "present"
           },
           "text": "don’t",
           "normalized": "don’t"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "business work"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "make",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " In making them faster, more productive, and more secure, we don’t just make business work better, we make the world work better.",
         "object": {
           "text": "the world"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "make",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We don’t just drive business value, we drive progress.",
         "object": {
           "text": "n’t just drive business value"
         },
         "action": {
           "verb": {
             "text": "do",
             "tense": "present"
           },
           "text": "do",
           "normalized": "do"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We don’t just drive business value, we drive progress.",
         "object": {
           "text": "just drive business value"
         },
         "action": {
           "verb": {
             "text": "n’t",
             "tense": "present"
           },
           "text": "don’t",
           "normalized": "don’t"
         }
       },
       {
         "subject": {
           "text": "we"
         },
         "sentence": " We don’t just drive business value, we drive progress.",
         "object": {
           "text": "progress"
         },
         "action": {
           "verb": {
             "text": "drive",
             "tense": "present"
           },
           "text": "drive",
           "normalized": "drive"
         }
       },
       {
         "subject": {
           "text": "I"
         },
         "sentence": " I believe IBM is uniquely suited to be the catalyst of that progress for decades to come.",
         "object": {
           "text": "IBM is uniquely suited to be the catalyst of that progress for decades to come"
         },
         "action": {
           "verb": {
             "text": "believe",
             "tense": "present"
           },
           "text": "believe",
           "normalized": "believe"
         }
       },
       {
         "subject": {
           "text": "IBM"
         },
         "sentence": " I believe IBM is uniquely suited to be the catalyst of that progress for decades to come.",
         "object": {
           "text": "to be the catalyst of that progress for decades to come"
         },
         "action": {
           "verb": {
             "text": "suit",
             "tense": "past"
           },
           "text": "suited",
           "normalized": "suit"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This is today’s IBM.",
         "object": {
           "text": "today’s IBM"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "data"
         },
         "sentence": " Prolifics developed its flexible Quick FHIR solution to rapidly standardize disparate health record formats, securely share data within a system, and reveal trends and predictors from patient histories",
         "object": {
           "text": "within a system, and reveal trends and predictors from patient histories"
         },
         "action": {
           "verb": {
             "text": "share",
             "tense": "present"
           },
           "text": "share",
           "normalized": "share"
         }
       },
       {
         "subject": {
           "text": "Prolifics"
         },
         "sentence": " Prolifics developed its flexible Quick FHIR solution to rapidly standardize disparate health record formats, securely share data within a system, and reveal trends and predictors from patient histories",
         "object": {
           "text": "trends and predictors from patient histories"
         },
         "action": {
           "verb": {
             "text": "reveal",
             "tense": "present"
           },
           "text": "reveal",
           "normalized": "reveal"
         }
       }
     ],
     "retrieved_url": "https://www.ibm.com/us-en/?ar=1",
     "relations": [
       {
         "type": "timeOf",
         "sentence": "From the acquisition of Red Hat to this week's spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "score": 0.84624,
         "arguments": [
           {
             "text": "this week",
             "location": [
               35,
               44
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "this week"
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               9,
               20
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "basedIn",
         "sentence": "From the acquisition of Red Hat to this week's spinoff of Kyndryl, IBM has taken decisive actions to become more strategic, focused and nimble IBM has always believed in the fundamental promise of technology — that when we apply innovation to real-world problems, we drive progress, for both business and society.",
         "score": 0.56273,
         "arguments": [
           {
             "text": "IBM",
             "location": [
               67,
               70
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "Kyndryl",
             "location": [
               58,
               65
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Kyndryl"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday's spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "score": 0.546185,
         "arguments": [
           {
             "text": "IBM",
             "location": [
               760,
               763
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               856,
               867
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday's spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "score": 0.468712,
         "arguments": [
           {
             "text": "our",
             "location": [
               852,
               855
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "them"
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               856,
               867
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday's spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "score": 0.862317,
         "arguments": [
           {
             "text": "2019",
             "location": [
               882,
               886
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "2019"
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               856,
               867
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "IBM has taken decisive strategic actions to meet the unique needs of this moment, including our acquisition of Red Hat in 2019 and yesterday's spinoff of our managed infrastructure services business, now known as Kyndryl.",
         "score": 0.46787,
         "arguments": [
           {
             "text": "yesterday",
             "location": [
               891,
               900
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "yesterday"
               }
             ]
           },
           {
             "text": "acquisition",
             "location": [
               856,
               867
             ],
             "entities": [
               {
                 "type": "EventBusiness",
                 "text": "acquisition"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "To do this, we have: Refocused our company around two primary sources of client value: technology and business expertise.",
         "score": 0.328285,
         "arguments": [
           {
             "text": "our",
             "location": [
               1170,
               1173
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "them"
               }
             ]
           },
           {
             "text": "company",
             "location": [
               1174,
               1181
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "company"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "We are better able to integrate technology and expertise to solve our clients' problems, regardless of whether the solutions come from IBM, our business partners, or even our competitors.",
         "score": 0.509207,
         "arguments": [
           {
             "text": "partners",
             "location": [
               1716,
               1724
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "partners"
               }
             ]
           },
           {
             "text": "our",
             "location": [
               1703,
               1706
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "employedBy",
         "sentence": "IBM's clients own and operate the most mission-critical systems on the planet: electrical grids, airlines, mobile networks, banks, and many others.",
         "score": 0.538102,
         "arguments": [
           {
             "text": "clients",
             "location": [
               1757,
               1764
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clients"
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               1751,
               1754
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "IBM Logo",
       "publication_date": "2021-11-04T00:00:00",
       "image": "",
       "feeds": [],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "acquisition of Red Hat",
         "relevance": 0.649907,
         "count": 2
       },
       {
         "text": "decisive actions",
         "relevance": 0.614996,
         "count": 1
       },
       {
         "text": "unique needs of this moment",
         "relevance": 0.614275,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.600406,
         "count": 8
       },
       {
         "text": "fundamental promise of technology",
         "relevance": 0.59605,
         "count": 1
       },
       {
         "text": "real-world problems",
         "relevance": 0.593631,
         "count": 1
       },
       {
         "text": "week’s spinoff",
         "relevance": 0.580508,
         "count": 1
       },
       {
         "text": "decisive strategic actions",
         "relevance": 0.578441,
         "count": 1
       },
       {
         "text": "primary sources of client value",
         "relevance": 0.576429,
         "count": 1
       },
       {
         "text": "flexible Quick FHIR solution",
         "relevance": 0.559928,
         "count": 1
       },
       {
         "text": "mission-critical systems",
         "relevance": 0.556944,
         "count": 1
       },
       {
         "text": "disparate health record formats",
         "relevance": 0.548502,
         "count": 1
       },
       {
         "text": "mobile networks",
         "relevance": 0.547862,
         "count": 1
       },
       {
         "text": "nature of those problems",
         "relevance": 0.547704,
         "count": 1
       },
       {
         "text": "core values",
         "relevance": 0.54094,
         "count": 1
       },
       {
         "text": "clients",
         "relevance": 0.539836,
         "count": 1
       },
       {
         "text": "foundational technologies",
         "relevance": 0.538452,
         "count": 1
       },
       {
         "text": "IBM’s clients",
         "relevance": 0.534676,
         "count": 1
       },
       {
         "text": "clients’ success",
         "relevance": 0.533768,
         "count": 1
       },
       {
         "text": "clients’ problems",
         "relevance": 0.524586,
         "count": 1
       },
       {
         "text": "goal",
         "relevance": 0.524118,
         "count": 1
       },
       {
         "text": "business partners",
         "relevance": 0.523463,
         "count": 1
       },
       {
         "text": "yesterday’s spinoff",
         "relevance": 0.520431,
         "count": 1
       },
       {
         "text": "today’s IBM",
         "relevance": 0.520217,
         "count": 1
       },
       {
         "text": "business expertise",
         "relevance": 0.518994,
         "count": 1
       },
       {
         "text": "electrical grids",
         "relevance": 0.518439,
         "count": 1
       },
       {
         "text": "common barriers",
         "relevance": 0.517244,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.517065,
         "count": 1
       },
       {
         "text": "innovation",
         "relevance": 0.516382,
         "count": 3
       },
       {
         "text": "business",
         "relevance": 0.515292,
         "count": 1
       },
       {
         "text": "value",
         "relevance": 0.514726,
         "count": 1
       },
       {
         "text": "modern society",
         "relevance": 0.513796,
         "count": 1
       },
       {
         "text": "today",
         "relevance": 0.513157,
         "count": 1
       },
       {
         "text": "company",
         "relevance": 0.511168,
         "count": 1
       },
       {
         "text": "ability",
         "relevance": 0.5107,
         "count": 1
       },
       {
         "text": "infrastructure services business",
         "relevance": 0.510211,
         "count": 1
       },
       {
         "text": "planet",
         "relevance": 0.509161,
         "count": 1
       },
       {
         "text": "airlines",
         "relevance": 0.508503,
         "count": 1
       },
       {
         "text": "business work",
         "relevance": 0.507393,
         "count": 1
       },
       {
         "text": "proprietary technologies",
         "relevance": 0.507105,
         "count": 1
       },
       {
         "text": "data",
         "relevance": 0.506771,
         "count": 1
       },
       {
         "text": "technology",
         "relevance": 0.506249,
         "count": 2
       },
       {
         "text": "services",
         "relevance": 0.505455,
         "count": 1
       },
       {
         "text": "expertise",
         "relevance": 0.505362,
         "count": 1
       },
       {
         "text": "banks",
         "relevance": 0.505038,
         "count": 1
       },
       {
         "text": "matters",
         "relevance": 0.504858,
         "count": 1
       },
       {
         "text": "progress",
         "relevance": 0.504742,
         "count": 2
       },
       {
         "text": "equity",
         "relevance": 0.504007,
         "count": 1
       },
       {
         "text": "trends",
         "relevance": 0.504007,
         "count": 1
       },
       {
         "text": "obstacles",
         "relevance": 0.503675,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.981358,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 11,
         "confidence": 1
       },
       {
         "type": "Organization",
         "text": "Kyndryl",
         "relevance": 0.716711,
         "count": 2,
         "confidence": 0.928104
       },
       {
         "type": "Organization",
         "text": "Red Hat",
         "relevance": 0.170142,
         "disambiguation": {
           "subtype": [
             "Company",
             "SoftwareDeveloper",
             "VentureFundedCompany",
             "VideoGamePublisher"
           ],
           "name": "Red_Hat",
           "dbpedia_resource": "http://dbpedia.org/resource/Red_Hat"
         },
         "count": 1,
         "confidence": 0.699293
       },
       {
         "type": "Organization",
         "text": "Prolifics",
         "relevance": 0.044968,
         "count": 1,
         "confidence": 0.901254
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.106702,
           "joy": 0.6178,
           "fear": 0.05546,
           "disgust": 0.028805,
           "anger": 0.09705
         }
       }
     },
     "concepts": [
       {
         "text": "Technology",
         "relevance": 0.948274,
         "dbpedia_resource": "http://dbpedia.org/resource/Technology"
       },
       {
         "text": "Economic growth",
         "relevance": 0.617515,
         "dbpedia_resource": "http://dbpedia.org/resource/Economic_growth"
       },
       {
         "text": "Sociology",
         "relevance": 0.573641,
         "dbpedia_resource": "http://dbpedia.org/resource/Sociology"
       },
       {
         "text": "2002 albums",
         "relevance": 0.527353,
         "dbpedia_resource": "http://dbpedia.org/resource/2002_albums"
       },
       {
         "text": "System",
         "relevance": 0.507223,
         "dbpedia_resource": "http://dbpedia.org/resource/System"
       },
       {
         "text": "Innovation",
         "relevance": 0.493967,
         "dbpedia_resource": "http://dbpedia.org/resource/Innovation"
       },
       {
         "text": "Linux",
         "relevance": 0.485822,
         "dbpedia_resource": "http://dbpedia.org/resource/Linux"
       },
       {
         "text": "Corporation",
         "relevance": 0.485235,
         "dbpedia_resource": "http://dbpedia.org/resource/Corporation"
       }
     ],
     "categories": [
       {
         "score": 0.907615,
         "label": "/business and industrial/business software"
       },
       {
         "score": 0.899929,
         "label": "/technology and computing"
       },
       {
         "score": 0.898749,
         "label": "/business and industrial/business operations/management/business process"
       }
     ]
   }






   ##########
   test:1636097399
   {
     "error": "invalid request format for 'categories'",
     "code": 400
   }






   ##########
   test:1636097451
   {
     "error": "invalid request format for 'categories'",
     "code": 400
   }






   ##########
   test:1636097471
   {
     "error": "invalid request format for 'categories'",
     "code": 400
   }






   ##########
   test:1636097511
   {
     "error": "invalid request format for 'categories'",
     "code": 400
   }






   ##########
   test:1636097569
   {
     "error": "invalid request format for 'categories'",
     "code": 400
   }






   ##########
   test:1636097989
   {
     "error": "invalid request format for 'concepts'",
     "code": 400
   }






   ##########
   test:1636098204
   {
     "error": "invalid request format for 'emotion'",
     "code": 400
   }






   ##########
   test:1636098232
   {
     "error": "invalid request format for 'emotion'",
     "code": 400
   }






   ##########
   test:1636098245
   {
     "error": "invalid request format for 'emotion'",
     "code": 400
   }






   ##########
   test:1636098260
   {
     "error": "invalid request format for 'emotion'",
     "code": 400
   }






   ##########
   test:1636098401
   {
     "error": "invalid request format for 'emotion'",
     "code": 400
   }






   ##########
   test:1636098831
   {
     "error": "invalid request format for 'metadata'",
     "code": 400
   }






   ##########
   test:1636098870
   {
     "error": "invalid request format for 'metadata'",
     "code": 400
   }






   ##########
   test:1636098887
   {
     "error": "invalid request format for 'metadata'",
     "code": 400
   }






   ##########
   test:1636098912
   {
     "error": "invalid request format for 'metadata'",
     "code": 400
   }






   ##########
   test:1636098939
   {
     "error": "feature '0' is not valid",
     "code": 400
   }






   ##########
   test:1636098961
   {
     "error": "invalid request format for 'metadata'",
     "code": 400
   }






   ##########
   test:1636099372
   {
     "error": "invalid request format for 'relations'",
     "code": 400
   }






   ##########
   test:1636099393
   {
     "language": "en",
     "error": "emotion request must specify at least one of: document, targets",
     "code": 400
   }






   ##########
   test:1636099420
   {
     "usage": {
       "text_units": 1,
       "text_characters": 337,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0,
         "label": "neutral"
       }
     },
     "semantic_roles": [],
     "retrieved_url": "https://www.google.com/",
     "relations": [],
     "metadata": {
       "title": "Google",
       "publication_date": "",
       "image": "/images/branding/googleg/1x/googleg_standard_color_128dp.png",
       "feeds": [],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Privacy Terms",
         "relevance": 0.895602,
         "count": 1
       },
       {
         "text": "Dark theme",
         "relevance": 0.820979,
         "count": 1
       },
       {
         "text": "search",
         "relevance": 0.608284,
         "count": 2
       },
       {
         "text": "Business",
         "relevance": 0.570242,
         "count": 1
       },
       {
         "text": "Google",
         "relevance": 0.567808,
         "count": 1
       },
       {
         "text": "data",
         "relevance": 0.55997,
         "count": 1
       },
       {
         "text": "settings",
         "relevance": 0.536814,
         "count": 1
       },
       {
         "text": "history",
         "relevance": 0.536814,
         "count": 1
       },
       {
         "text": "help",
         "relevance": 0.536814,
         "count": 1
       },
       {
         "text": "feedback",
         "relevance": 0.536814,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Google",
         "relevance": 0.978348,
         "disambiguation": {
           "subtype": [
             "AcademicInstitution",
             "AwardPresentingOrganization",
             "Company",
             "OperatingSystemDeveloper",
             "ProgrammingLanguageDeveloper",
             "SoftwareDeveloper",
             "VentureFundedCompany"
           ],
           "name": "Google",
           "dbpedia_resource": "http://dbpedia.org/resource/Google"
         },
         "count": 2,
         "confidence": 0.998455
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.156689,
           "joy": 0.071622,
           "fear": 0.02614,
           "disgust": 0.050511,
           "anger": 0.026519
         }
       }
     },
     "concepts": [
       {
         "text": "Google Apps",
         "relevance": 0.958178,
         "dbpedia_resource": "http://dbpedia.org/resource/Google_Apps"
       },
       {
         "text": "Google",
         "relevance": 0.928407,
         "dbpedia_resource": "http://dbpedia.org/resource/Google"
       },
       {
         "text": "Gmail",
         "relevance": 0.733964,
         "dbpedia_resource": "http://dbpedia.org/resource/Gmail"
       },
       {
         "text": "Google services",
         "relevance": 0.528571,
         "dbpedia_resource": "http://dbpedia.org/resource/Google_services"
       },
       {
         "text": "HIStory: Past, Present and Future, Book I",
         "relevance": 0.508939,
         "dbpedia_resource": "http://dbpedia.org/resource/HIStory:_Past,_Present_and_Future,_Book_I"
       },
       {
         "text": "Neutral level",
         "relevance": 0.495591,
         "dbpedia_resource": "http://dbpedia.org/resource/Neutral_level"
       }
     ],
     "categories": [
       {
         "score": 0.999853,
         "label": "/technology and computing/internet technology/web search/people search"
       }
     ]
   }






   ##########
   test:1636101347
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       },
       {
         "text": "Cirrhosis",
         "relevance": 0.5346,
         "dbpedia_resource": "http://dbpedia.org/resource/Cirrhosis"
       },
       {
         "text": "Decision support system",
         "relevance": 0.514124,
         "dbpedia_resource": "http://dbpedia.org/resource/Decision_support_system"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       },
       {
         "score": 0.723374,
         "label": "/business and industrial/business software"
       },
       {
         "score": 0.703722,
         "label": "/health and fitness/men's health"
       }
     ]
   }






   ##########
   test:1636101396
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636101633
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636101763
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636101826
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636101991
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636102122
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636102204
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636102261
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636102286
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636102370
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636102873
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636102937
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636102988
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636103973
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636103988
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636104606
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636104637
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636104695
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636104817
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
   test:1636104868
   {
     "usage": {
       "text_units": 1,
       "text_characters": 4275,
       "features": 9
     },
     "sentiment": {
       "document": {
         "score": 0.690499,
         "label": "positive"
       }
     },
     "semantic_roles": [
       {
         "subject": {
           "text": "CEST"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "30"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "am",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "agents and solutions for diagnostic and interventional medical imaging,"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "announce",
             "tense": "past"
           },
           "text": "announced",
           "normalized": "announce"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "it"
         },
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "object": {
           "text": "utilizing CT and MRI imaging"
         },
         "action": {
           "verb": {
             "text": "care",
             "tense": "present"
           },
           "text": "care",
           "normalized": "care"
         }
       },
       {
         "subject": {
           "text": "Guerbet and IBM Watson Health"
         },
         "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
         "object": {
           "text": "innovative, clinical decision support solutions"
         },
         "action": {
           "verb": {
             "text": "co-develop",
             "tense": "future"
           },
           "text": "to co-develop",
           "normalized": "to co-develop"
         }
       },
       {
         "subject": {
           "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "planned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "a diagnostic support tool"
         },
         "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "object": {
           "text": "artificial intelligence"
         },
         "action": {
           "verb": {
             "text": "use",
             "tense": "future"
           },
           "text": "will use",
           "normalized": "will use"
         }
       },
       {
         "subject": {
           "text": "the solutions"
         },
         "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
         "object": {
           "text": "prior research innovations"
         },
         "action": {
           "verb": {
             "text": "leverage",
             "tense": "present"
           },
           "text": "leveraging",
           "normalized": "leverage"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "the second leading cause of cancer death worldwide"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "nearly 50% of patients"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "metastases."
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "present"
           },
           "text": "develop",
           "normalized": "develop"
         }
       },
       {
         "subject": {
           "text": "The hope"
         },
         "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
         "object": {
           "text": "that better characterization"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Liver cancer"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "a growing health concern"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "well positioned"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "to help address it"
         },
         "action": {
           "verb": {
             "text": "position",
             "tense": "past"
           },
           "text": "positioned",
           "normalized": "position"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "address it"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "the use of augmented intelligence by medical imaging"
         },
         "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
         "object": {
           "text": "it"
         },
         "action": {
           "verb": {
             "text": "address",
             "tense": "present"
           },
           "text": "to help address",
           "normalized": "to help address"
         }
       },
       {
         "subject": {
           "text": "IBM Watson Health"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "develop",
             "tense": "future"
           },
           "text": "to develop",
           "normalized": "to develop"
         }
       },
       {
         "subject": {
           "text": "a solution dedicated to liver disease"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "for clinicians"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "future"
           },
           "text": "could help make",
           "normalized": "could help make"
         }
       },
       {
         "subject": {
           "text": "characterizations"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "of tissue"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "past"
           },
           "text": "informed",
           "normalized": "inform"
         }
       },
       {
         "subject": {
           "text": "Yves L’Epine, Guerbet’s CEO"
         },
         "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
         "object": {
           "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "to be integrated directly into the workflows of healthcare professionals"
         },
         "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "object": {
           "text": "easy"
         },
         "action": {
           "verb": {
             "text": "make",
             "tense": "present"
           },
           "text": "making",
           "normalized": "make"
         }
       },
       {
         "subject": {
           "text": "Imaging"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "artificial intelligence"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "the physician’s view"
         },
         "action": {
           "verb": {
             "text": "expand",
             "tense": "future"
           },
           "text": "to expand",
           "normalized": "to expand"
         }
       },
       {
         "subject": {
           "text": "they"
         },
         "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "object": {
           "text": "more informed in their diagnostic"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "future"
           },
           "text": "be",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We"
         },
         "action": {
           "verb": {
             "text": "excite",
             "tense": "past"
           },
           "text": "excited",
           "normalized": "excite"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "the significant respective expertise of IBM and Guerbet"
         },
         "action": {
           "verb": {
             "text": "bring",
             "tense": "future"
           },
           "text": "are excited to bring",
           "normalized": "be excite to bring"
         }
       },
       {
         "subject": {
           "text": "innovation"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "advance",
             "tense": "future"
           },
           "text": "to advance",
           "normalized": "to advance"
         }
       },
       {
         "subject": {
           "text": "combat the challenge of liver cancer globally"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "action": {
           "verb": {
             "text": "help",
             "tense": "present"
           },
           "text": "help",
           "normalized": "help"
         }
       },
       {
         "subject": {
           "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
         },
         "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "object": {
           "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "by IBM Watson image analytics"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "support tools"
         },
         "action": {
           "verb": {
             "text": "power",
             "tense": "past"
           },
           "text": "powered",
           "normalized": "power"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
         "object": {
           "text": "diagnostic decisions for their patients"
         },
         "action": {
           "verb": {
             "text": "inform",
             "tense": "future"
           },
           "text": "designed to inform",
           "normalized": "design to inform"
         }
       },
       {
         "subject": {
           "text": "These offerings"
         },
         "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
         "object": {
           "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
         },
         "action": {
           "verb": {
             "text": "create",
             "tense": "future"
           },
           "text": "to create",
           "normalized": "to create"
         }
       },
       {
         "subject": {
           "text": "We"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "to working with IBM Watson Health"
         },
         "action": {
           "verb": {
             "text": "look",
             "tense": "present"
           },
           "text": "look",
           "normalized": "look"
         }
       },
       {
         "subject": {
           "text": "first project"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "at better assisting radiologists with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "aim",
             "tense": "past"
           },
           "text": "aimed",
           "normalized": "aim"
         }
       },
       {
         "subject": {
           "text": "radiologists"
         },
         "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
         "object": {
           "text": "with augmented intelligence"
         },
         "action": {
           "verb": {
             "text": "assist",
             "tense": "present"
           },
           "text": "assisting",
           "normalized": "assist"
         }
       },
       {
         "subject": {
           "text": "This"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "us grow our capabilities"
         },
         "action": {
           "verb": {
             "text": "help",
             "tense": "future"
           },
           "text": "will help",
           "normalized": "will help"
         }
       },
       {
         "subject": {
           "text": "François Nicolas, Chief Digital Officer at Guerbet"
         },
         "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
         "object": {
           "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
         },
         "action": {
           "verb": {
             "text": "say",
             "tense": "past"
           },
           "text": "said",
           "normalized": "say"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "object": {
           "text": "a pioneer in the contrast-agent field"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Guerbet"
         },
         "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "It"
         },
         "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
         "object": {
           "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
         },
         "action": {
           "verb": {
             "text": "offer",
             "tense": "present"
           },
           "text": "offers",
           "normalized": "offer"
         }
       },
       {
         "subject": {
           "text": "8% of revenue"
         },
         "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "object": {
           "text": "to R&D and more than 200 employees"
         },
         "action": {
           "verb": {
             "text": "dedicate",
             "tense": "past"
           },
           "text": "dedicated",
           "normalized": "dedicate"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "on Euronext Paris (segment B – mid caps)"
         },
         "action": {
           "verb": {
             "text": "list",
             "tense": "past"
           },
           "text": "is listed",
           "normalized": "be list"
         }
       },
       {
         "subject": {
           "text": "Guerbet (GBT)"
         },
         "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
         "object": {
           "text": "€807 million in revenue"
         },
         "action": {
           "verb": {
             "text": "generate",
             "tense": "past"
           },
           "text": "generated",
           "normalized": "generate"
         }
       },
       {
         "subject": {
           "text": "Watson Health"
         },
         "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
         "object": {
           "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "is",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "be",
             "tense": "present"
           },
           "text": "are",
           "normalized": "be"
         }
       },
       {
         "subject": {
           "text": "Watson Health technologies"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
         },
         "action": {
           "verb": {
             "text": "tackle",
             "tense": "present"
           },
           "text": "are tackling",
           "normalized": "be tackle"
         }
       },
       {
         "subject": {
           "text": "cancer, diabetes, drug discovery and more"
         },
         "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
         "object": {
           "text": "a wide range of the world’s biggest healthcare challenges"
         },
         "action": {
           "verb": {
             "text": "include",
             "tense": "present"
           },
           "text": "including",
           "normalized": "include"
         }
       },
       {
         "subject": {
           "text": "more"
         },
         "sentence": " Learn more at ibm.com/watson/health ",
         "object": {
           "text": "at ibm.com/watson/health"
         },
         "action": {
           "verb": {
             "text": "Learn",
             "tense": "present"
           },
           "text": "Learn",
           "normalized": "Learn"
         }
       }
     ],
     "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
     "relations": [
       {
         "type": "locatedAt",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.672592,
         "arguments": [
           {
             "text": "Cambridge",
             "location": [
               24,
               33
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Cambridge"
               }
             ]
           },
           {
             "text": "USA",
             "location": [
               35,
               38
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "United States",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.69467,
         "arguments": [
           {
             "text": "their",
             "location": [
               2251,
               2256
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
         "score": 0.179295,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2302,
               2310
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2296,
               2301
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "their"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.79643,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               2393,
               2400
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "liver cancer",
             "location": [
               2492,
               2504
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "liver cancer"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.954126,
         "arguments": [
           {
             "text": "Anne Le Grand",
             "location": [
               2521,
               2534
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               2516,
               2520
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
         "score": 0.570255,
         "arguments": [
           {
             "text": "Vice President of Imaging",
             "location": [
               2536,
               2561
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Anne Le Grand"
               }
             ]
           },
           {
             "text": "Watson Health",
             "location": [
               2565,
               2578
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.548518,
         "arguments": [
           {
             "text": "radiologists",
             "location": [
               2728,
               2740
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "radiologists"
               }
             ]
           },
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           }
         ]
       },
       {
         "type": "partOfMany",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.227306,
         "arguments": [
           {
             "text": "patients",
             "location": [
               2773,
               2781
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "their",
             "location": [
               2767,
               2772
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "family"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.760628,
         "arguments": [
           {
             "text": "François Nicolas",
             "location": [
               3191,
               3207
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               3186,
               3190
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
         "score": 0.542882,
         "arguments": [
           {
             "text": "Chief Digital Officer",
             "location": [
               3209,
               3230
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "François Nicolas"
               }
             ]
           },
           {
             "text": "Guerbet",
             "location": [
               3234,
               3241
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "Guerbet"
               }
             ]
           }
         ]
       },
       {
         "type": "locatedAt",
         "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
         "score": 0.506287,
         "arguments": [
           {
             "text": "employees",
             "location": [
               3614,
               3623
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "employees"
               }
             ]
           },
           {
             "text": "France",
             "location": [
               3659,
               3665
             ],
             "entities": [
               {
                 "type": "GeopoliticalEntity",
                 "text": "France",
                 "disambiguation": {
                   "subtype": [
                     "Country"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "timeOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.965172,
         "arguments": [
           {
             "text": "today",
             "location": [
               185,
               190
             ],
             "entities": [
               {
                 "type": "Date",
                 "text": "today"
               }
             ]
           },
           {
             "text": "announced",
             "location": [
               191,
               200
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "announced"
               }
             ]
           }
         ]
       },
       {
         "type": "partOf",
         "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
         "score": 0.521439,
         "arguments": [
           {
             "text": "Watson Health",
             "location": [
               360,
               373
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           },
           {
             "text": "IBM",
             "location": [
               355,
               358
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "IBM Watson Health",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.607758,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               613,
               620
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               593,
               612
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
         "score": 0.827154,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               2600,
               2607
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Watson Imaging Care",
             "location": [
               2580,
               2599
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
         "score": 0.829171,
         "arguments": [
           {
             "text": "clinicians",
             "location": [
               856,
               866
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "clinicians"
               }
             ]
           },
           {
             "text": "cancer",
             "location": [
               845,
               851
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "hasAttribute",
         "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
         "score": 0.750776,
         "arguments": [
           {
             "text": "patients",
             "location": [
               1318,
               1326
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "patients"
               }
             ]
           },
           {
             "text": "cancers",
             "location": [
               1286,
               1293
             ],
             "entities": [
               {
                 "type": "HealthCondition",
                 "text": "cancers"
               }
             ]
           }
         ]
       },
       {
         "type": "agentOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.896574,
         "arguments": [
           {
             "text": "Yves L’Epine",
             "location": [
               1868,
               1880
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           },
           {
             "text": "said",
             "location": [
               1863,
               1867
             ],
             "entities": [
               {
                 "type": "EventCommunication",
                 "text": "said"
               }
             ]
           }
         ]
       },
       {
         "type": "clientOf",
         "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
         "score": 0.409639,
         "arguments": [
           {
             "text": "Guerbet",
             "location": [
               1882,
               1889
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Guerbet"
               }
             ]
           },
           {
             "text": "CEO",
             "location": [
               1892,
               1895
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Yves L’Epine"
               }
             ]
           }
         ]
       },
       {
         "type": "managerOf",
         "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
         "score": 0.771235,
         "arguments": [
           {
             "text": "Advisor",
             "location": [
               1902,
               1909
             ],
             "entities": [
               {
                 "type": "Person",
                 "text": "Advisor"
               }
             ]
           },
           {
             "text": "Care",
             "location": [
               1897,
               1901
             ],
             "entities": [
               {
                 "type": "Organization",
                 "text": "Watson Imaging Care",
                 "disambiguation": {
                   "subtype": [
                     "Commercial"
                   ]
                 }
               }
             ]
           }
         ]
       }
     ],
     "metadata": {
       "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
       "publication_date": "2018-07-10T00:00:00",
       "image": "",
       "feeds": [
         {
           "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
         }
       ],
       "authors": []
     },
     "language": "en",
     "keywords": [
       {
         "text": "Watson Health",
         "relevance": 0.716382,
         "count": 3
       },
       {
         "text": "liver cancer diagnostics",
         "relevance": 0.680537,
         "count": 1
       },
       {
         "text": "IBM Watson Health plan",
         "relevance": 0.624009,
         "count": 1
       },
       {
         "text": "artificial intelligence",
         "relevance": 0.616959,
         "count": 3
       },
       {
         "text": "secondary liver cancer",
         "relevance": 0.572779,
         "count": 1
       },
       {
         "text": "interventional medical imaging",
         "relevance": 0.570391,
         "count": 1
       },
       {
         "text": "Liver cancer",
         "relevance": 0.569905,
         "count": 2
       },
       {
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.566132,
         "count": 2
       },
       {
         "text": "IBM Watson image analytics",
         "relevance": 0.565653,
         "count": 2
       },
       {
         "text": "IBM Watson Health",
         "relevance": 0.555159,
         "count": 2
       },
       {
         "text": "clinical decision support solutions",
         "relevance": 0.554027,
         "count": 1
       },
       {
         "text": "important field",
         "relevance": 0.551971,
         "count": 1
       },
       {
         "text": "IBM",
         "relevance": 0.550497,
         "count": 2
       },
       {
         "text": "common site",
         "relevance": 0.543831,
         "count": 1
       },
       {
         "text": "IBM Research team",
         "relevance": 0.54343,
         "count": 1
       },
       {
         "text": "Guerbet’s first project",
         "relevance": 0.543398,
         "count": 1
       },
       {
         "text": "medical imaging",
         "relevance": 0.539507,
         "count": 1
       },
       {
         "text": "diagnostic support tool",
         "relevance": 0.537071,
         "count": 1
       },
       {
         "text": "second leading cause of cancer death",
         "relevance": 0.535483,
         "count": 1
       },
       {
         "text": "Vice President",
         "relevance": 0.534637,
         "count": 1
       },
       {
         "text": "exclusive joint development agreement",
         "relevance": 0.533562,
         "count": 1
       },
       {
         "text": "innovative solutions",
         "relevance": 0.533158,
         "count": 1
       },
       {
         "text": "primary liver cancer cases",
         "relevance": 0.531554,
         "count": 1
       },
       {
         "text": "liver disease",
         "relevance": 0.530825,
         "count": 1
       },
       {
         "text": "Guerbet’s CEO",
         "relevance": 0.530769,
         "count": 1
       },
       {
         "text": "significant respective expertise of IBM",
         "relevance": 0.530481,
         "count": 1
       },
       {
         "text": "therapy prediction",
         "relevance": 0.528744,
         "count": 1
       },
       {
         "text": "medical devices",
         "relevance": 0.528408,
         "count": 1
       },
       {
         "text": "fastest growing cause of cancer deaths",
         "relevance": 0.528181,
         "count": 1
       },
       {
         "text": "United States",
         "relevance": 0.527403,
         "count": 2
       },
       {
         "text": "software solution",
         "relevance": 0.524276,
         "count": 1
       },
       {
         "text": "comprehensive range of pharmaceutical products",
         "relevance": 0.524195,
         "count": 1
       },
       {
         "text": "better characterization",
         "relevance": 0.523019,
         "count": 1
       },
       {
         "text": "informed characterizations of tissue",
         "relevance": 0.520003,
         "count": 1
       },
       {
         "text": "challenge of liver cancer",
         "relevance": 0.519166,
         "count": 1
       },
       {
         "text": "contrast agents",
         "relevance": 0.519015,
         "count": 1
       },
       {
         "text": "solutions",
         "relevance": 0.518529,
         "count": 1
       },
       {
         "text": "drug discovery",
         "relevance": 0.518322,
         "count": 1
       },
       {
         "text": "business unit of IBM",
         "relevance": 0.516144,
         "count": 1
       },
       {
         "text": "part of a family of decision support tools",
         "relevance": 0.514169,
         "count": 1
       },
       {
         "text": "shared objective",
         "relevance": 0.512652,
         "count": 1
       },
       {
         "text": "Anne Le Grand",
         "relevance": 0.512499,
         "count": 1
       },
       {
         "text": "collaboration",
         "relevance": 0.511784,
         "count": 2
       },
       {
         "text": "use",
         "relevance": 0.511673,
         "count": 1
       },
       {
         "text": "Liver",
         "relevance": 0.511563,
         "count": 4
       },
       {
         "text": "care",
         "relevance": 0.511533,
         "count": 1
       },
       {
         "text": "France",
         "relevance": 0.511131,
         "count": 2
       },
       {
         "text": "workflows of healthcare professionals",
         "relevance": 0.510525,
         "count": 1
       },
       {
         "text": "critical area of healthcare",
         "relevance": 0.50995,
         "count": 1
       },
       {
         "text": "offerings",
         "relevance": 0.508136,
         "count": 1
       }
     ],
     "entities": [
       {
         "type": "Organization",
         "text": "Guerbet",
         "relevance": 0.951857,
         "disambiguation": {
           "subtype": [
             "Company"
           ],
           "name": "Guerbet",
           "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
         },
         "count": 6,
         "confidence": 0.992578
       },
       {
         "type": "Organization",
         "text": "IBM Watson Health",
         "relevance": 0.845477,
         "count": 3,
         "confidence": 0.956563
       },
       {
         "type": "Organization",
         "text": "Watson Health",
         "relevance": 0.713947,
         "count": 4,
         "confidence": 0.994271
       },
       {
         "type": "JobTitle",
         "text": "Watson Imaging Care Advisor",
         "relevance": 0.636466,
         "count": 2,
         "confidence": 0.758272
       },
       {
         "type": "Location",
         "text": "Villepinte (France",
         "relevance": 0.522923,
         "count": 1,
         "confidence": 0.455182
       },
       {
         "type": "JobTitle",
         "text": "global specialist",
         "relevance": 0.51449,
         "count": 1,
         "confidence": 0.898168
       },
       {
         "type": "JobTitle",
         "text": "contrast agents",
         "relevance": 0.512437,
         "count": 1,
         "confidence": 0.513625
       },
       {
         "type": "Organization",
         "text": "IBM",
         "relevance": 0.472816,
         "disambiguation": {
           "subtype": [
             "SoftwareLicense",
             "Company",
             "OperatingSystemDeveloper",
             "ProcessorManufacturer",
             "SoftwareDeveloper",
             "CompanyFounder",
             "ProgrammingLanguageDesigner",
             "ProgrammingLanguageDeveloper"
           ],
           "name": "IBM",
           "dbpedia_resource": "http://dbpedia.org/resource/IBM"
         },
         "count": 4,
         "confidence": 0.999859
       },
       {
         "type": "Organization",
         "text": "IBM Watson",
         "relevance": 0.390354,
         "count": 2,
         "confidence": 0.777948
       },
       {
         "type": "Person",
         "text": "Yves L’Epine",
         "relevance": 0.318308,
         "count": 1,
         "confidence": 0.338964
       },
       {
         "type": "Organization",
         "text": "Guerbet’s CEO",
         "relevance": 0.316591,
         "count": 1,
         "confidence": 0.272542
       },
       {
         "type": "JobTitle",
         "text": "Care Advisor",
         "relevance": 0.314872,
         "count": 1,
         "confidence": 0.923817
       },
       {
         "type": "Organization",
         "text": "IBM Research",
         "relevance": 0.28884,
         "count": 1,
         "confidence": 0.854673
       },
       {
         "type": "Person",
         "text": "Anne Le Grand",
         "relevance": 0.238705,
         "count": 1,
         "confidence": 0.584993
       },
       {
         "type": "JobTitle",
         "text": "Vice President of Imaging",
         "relevance": 0.236068,
         "count": 1,
         "confidence": 0.492345
       },
       {
         "type": "Organization",
         "text": "NYSE",
         "relevance": 0.235366,
         "disambiguation": {
           "subtype": [
             "Location",
             "Company",
             "Facility",
             "HistoricPlace",
             "Building"
           ],
           "name": "New_York_Stock_Exchange",
           "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
         },
         "count": 1,
         "confidence": 0.934449
       },
       {
         "type": "Organization",
         "text": "MRI",
         "relevance": 0.232688,
         "count": 1,
         "confidence": 0.682634
       },
       {
         "type": "Location",
         "text": "Cambridge",
         "relevance": 0.227427,
         "count": 1,
         "confidence": 0.867439
       },
       {
         "type": "JobTitle",
         "text": "radiologists",
         "relevance": 0.205876,
         "count": 2,
         "confidence": 0.85016
       },
       {
         "type": "Location",
         "text": "USA",
         "relevance": 0.18222,
         "disambiguation": {
           "subtype": [
             "HumanLanguage",
             "PoliticalDistrict",
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction"
           ],
           "name": "Italy",
           "dbpedia_resource": "http://dbpedia.org/resource/Italy"
         },
         "count": 1,
         "confidence": 0.496166
       },
       {
         "type": "JobTitle",
         "text": "clinicians",
         "relevance": 0.162803,
         "count": 1,
         "confidence": 0.672112
       },
       {
         "type": "Person",
         "text": "François Nicolas",
         "relevance": 0.151782,
         "count": 1,
         "confidence": 0.984179
       },
       {
         "type": "JobTitle",
         "text": "Chief Digital Officer",
         "relevance": 0.149039,
         "count": 1,
         "confidence": 0.844456
       },
       {
         "type": "Location",
         "text": "United States",
         "relevance": 0.148527,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmEditor"
           ],
           "name": "United_States",
           "dbpedia_resource": "http://dbpedia.org/resource/United_States"
         },
         "count": 2,
         "confidence": 0.99803
       },
       {
         "type": "Person",
         "text": "Guerbet",
         "relevance": 0.145419,
         "count": 1,
         "confidence": 0.482155
       },
       {
         "type": "JobTitle",
         "text": "physician",
         "relevance": 0.107807,
         "count": 1,
         "confidence": 0.883194
       },
       {
         "type": "Organization",
         "text": "R&D",
         "relevance": 0.098017,
         "disambiguation": {
           "subtype": [
             "Industry"
           ],
           "name": "Research_and_development",
           "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
         },
         "count": 1,
         "confidence": 0.873433
       },
       {
         "type": "Organization",
         "text": "Guerbet (GBT",
         "relevance": 0.073968,
         "count": 1,
         "confidence": 0.308671
       },
       {
         "type": "Organization",
         "text": "Euronext Paris",
         "relevance": 0.048738,
         "count": 1,
         "confidence": 0.350544
       },
       {
         "type": "Location",
         "text": "France",
         "relevance": 0.02958,
         "disambiguation": {
           "subtype": [
             "Region",
             "AdministrativeDivision",
             "Country",
             "GovernmentalJurisdiction",
             "FilmDirector"
           ],
           "name": "France",
           "dbpedia_resource": "http://dbpedia.org/resource/France"
         },
         "count": 1,
         "confidence": 0.998555
       },
       {
         "type": "Location",
         "text": "Israel",
         "relevance": 0.028307,
         "disambiguation": {
           "subtype": [
             "Country",
             "GovernmentalJurisdiction",
             "FilmArtDirector"
           ],
           "name": "Israel",
           "dbpedia_resource": "http://dbpedia.org/resource/Israel"
         },
         "count": 1,
         "confidence": 0.920981
       }
     ],
     "emotion": {
       "document": {
         "emotion": {
           "sadness": 0.154,
           "joy": 0.580866,
           "fear": 0.064083,
           "disgust": 0.036787,
           "anger": 0.042247
         }
       }
     },
     "concepts": [
       {
         "text": "Cancer",
         "relevance": 0.956922,
         "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
       },
       {
         "text": "Health care",
         "relevance": 0.82318,
         "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
       },
       {
         "text": "Magnetic resonance imaging",
         "relevance": 0.649831,
         "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
       },
       {
         "text": "Medicine",
         "relevance": 0.625157,
         "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
       },
       {
         "text": "Artificial intelligence",
         "relevance": 0.580927,
         "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
       },
       {
         "text": "Oncology",
         "relevance": 0.553219,
         "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
       },
       {
         "text": "Liver",
         "relevance": 0.540594,
         "dbpedia_resource": "http://dbpedia.org/resource/Liver"
       },
       {
         "text": "Hepatocellular carcinoma",
         "relevance": 0.538087,
         "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
       }
     ],
     "categories": [
       {
         "score": 0.952376,
         "label": "/health and fitness"
       },
       {
         "score": 0.943401,
         "label": "/health and fitness/therapy"
       },
       {
         "score": 0.895604,
         "label": "/health and fitness/disease/cancer/brain tumor"
       }
     ]
   }






   ##########
test:1636152672
{
  "usage": {
    "text_units": 1,
    "text_characters": 4275,
    "features": 9
  },
  "sentiment": {
    "document": {
      "score": 0.690499,
      "label": "positive"
    }
  },
  "semantic_roles": [
    {
      "subject": {
        "text": "CEST"
      },
      "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
      "object": {
        "text": "30"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "am",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "agents and solutions for diagnostic and interventional medical imaging,"
      },
      "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
      "object": {
        "text": "that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
      },
      "action": {
        "verb": {
          "text": "announce",
          "tense": "past"
        },
        "text": "announced",
        "normalized": "announce"
      }
    },
    {
      "subject": {
        "text": "it"
      },
      "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
      "object": {
        "text": "an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging"
      },
      "action": {
        "verb": {
          "text": "develop",
          "tense": "future"
        },
        "text": "to develop",
        "normalized": "to develop"
      }
    },
    {
      "subject": {
        "text": "it"
      },
      "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) – Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
      "object": {
        "text": "utilizing CT and MRI imaging"
      },
      "action": {
        "verb": {
          "text": "care",
          "tense": "present"
        },
        "text": "care",
        "normalized": "care"
      }
    },
    {
      "subject": {
        "text": "Guerbet and IBM Watson Health"
      },
      "sentence": " Through this collaboration, Guerbet and IBM Watson Health plan to co-develop innovative, clinical decision support solutions.",
      "object": {
        "text": "innovative, clinical decision support solutions"
      },
      "action": {
        "verb": {
          "text": "co-develop",
          "tense": "future"
        },
        "text": "to co-develop",
        "normalized": "to co-develop"
      }
    },
    {
      "subject": {
        "text": "The first, called Watson Imaging Care Advisor[1] for Liver,"
      },
      "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
      "object": {
        "text": "planned"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "is",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "a diagnostic support tool"
      },
      "sentence": " The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
      "object": {
        "text": "artificial intelligence"
      },
      "action": {
        "verb": {
          "text": "use",
          "tense": "future"
        },
        "text": "will use",
        "normalized": "will use"
      }
    },
    {
      "subject": {
        "text": "the solutions"
      },
      "sentence": " The IBM Research team will also work on development of the solutions leveraging prior research innovations.",
      "object": {
        "text": "prior research innovations"
      },
      "action": {
        "verb": {
          "text": "leverage",
          "tense": "present"
        },
        "text": "leveraging",
        "normalized": "leverage"
      }
    },
    {
      "subject": {
        "text": "Liver cancer"
      },
      "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
      "object": {
        "text": "the second leading cause of cancer death worldwide"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "is",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "nearly 50% of patients"
      },
      "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
      "object": {
        "text": "metastases."
      },
      "action": {
        "verb": {
          "text": "develop",
          "tense": "present"
        },
        "text": "develop",
        "normalized": "develop"
      }
    },
    {
      "subject": {
        "text": "The hope"
      },
      "sentence": " Liver cancer is the second leading cause of cancer death worldwide,[2] and the fastest growing cause of cancer deaths in the United States.[3] About 83 percent of primary liver cancer cases occur in developing countries.[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.[5] The hope is that better characterization and earlier identification of these metastases may lead to an improvement in the chances of recovery.",
      "object": {
        "text": "that better characterization"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "is",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "Liver cancer"
      },
      "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
      "object": {
        "text": "a growing health concern"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "is",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "the use of augmented intelligence by medical imaging"
      },
      "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
      "object": {
        "text": "well positioned"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "is",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "the use of augmented intelligence by medical imaging"
      },
      "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
      "object": {
        "text": "to help address it"
      },
      "action": {
        "verb": {
          "text": "position",
          "tense": "past"
        },
        "text": "positioned",
        "normalized": "position"
      }
    },
    {
      "subject": {
        "text": "the use of augmented intelligence by medical imaging"
      },
      "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
      "object": {
        "text": "address it"
      },
      "action": {
        "verb": {
          "text": "help",
          "tense": "future"
        },
        "text": "help",
        "normalized": "help"
      }
    },
    {
      "subject": {
        "text": "the use of augmented intelligence by medical imaging"
      },
      "sentence": " “Liver cancer is a growing health concern globally, and the use of augmented intelligence by medical imaging is well positioned to help address it.",
      "object": {
        "text": "it"
      },
      "action": {
        "verb": {
          "text": "address",
          "tense": "present"
        },
        "text": "to help address",
        "normalized": "to help address"
      }
    },
    {
      "subject": {
        "text": "IBM Watson Health"
      },
      "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
      "object": {
        "text": "a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
      },
      "action": {
        "verb": {
          "text": "develop",
          "tense": "future"
        },
        "text": "to develop",
        "normalized": "to develop"
      }
    },
    {
      "subject": {
        "text": "a solution dedicated to liver disease"
      },
      "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
      "object": {
        "text": "for clinicians"
      },
      "action": {
        "verb": {
          "text": "make",
          "tense": "future"
        },
        "text": "could help make",
        "normalized": "could help make"
      }
    },
    {
      "subject": {
        "text": "characterizations"
      },
      "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
      "object": {
        "text": "of tissue"
      },
      "action": {
        "verb": {
          "text": "inform",
          "tense": "past"
        },
        "text": "informed",
        "normalized": "inform"
      }
    },
    {
      "subject": {
        "text": "Yves L’Epine, Guerbet’s CEO"
      },
      "sentence": " We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,” said Yves L’Epine, Guerbet’s CEO.",
      "object": {
        "text": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy"
      },
      "action": {
        "verb": {
          "text": "say",
          "tense": "past"
        },
        "text": "said",
        "normalized": "say"
      }
    },
    {
      "subject": {
        "text": "to be integrated directly into the workflows of healthcare professionals"
      },
      "sentence": " Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
      "object": {
        "text": "easy"
      },
      "action": {
        "verb": {
          "text": "make",
          "tense": "present"
        },
        "text": "making",
        "normalized": "make"
      }
    },
    {
      "subject": {
        "text": "Imaging"
      },
      "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
      "object": {
        "text": "a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "is",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "artificial intelligence"
      },
      "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
      "object": {
        "text": "the physician’s view"
      },
      "action": {
        "verb": {
          "text": "expand",
          "tense": "future"
        },
        "text": "to expand",
        "normalized": "to expand"
      }
    },
    {
      "subject": {
        "text": "they"
      },
      "sentence": " “Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician’s view so they can be more informed in their diagnostic and treatment decisions for their patients.",
      "object": {
        "text": "more informed in their diagnostic"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "future"
        },
        "text": "be",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field"
      },
      "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
      "object": {
        "text": "We"
      },
      "action": {
        "verb": {
          "text": "excite",
          "tense": "past"
        },
        "text": "excited",
        "normalized": "excite"
      }
    },
    {
      "subject": {
        "text": "We"
      },
      "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
      "object": {
        "text": "the significant respective expertise of IBM and Guerbet"
      },
      "action": {
        "verb": {
          "text": "bring",
          "tense": "future"
        },
        "text": "are excited to bring",
        "normalized": "be excite to bring"
      }
    },
    {
      "subject": {
        "text": "innovation"
      },
      "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
      "action": {
        "verb": {
          "text": "advance",
          "tense": "future"
        },
        "text": "to advance",
        "normalized": "to advance"
      }
    },
    {
      "subject": {
        "text": "combat the challenge of liver cancer globally"
      },
      "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
      "action": {
        "verb": {
          "text": "help",
          "tense": "present"
        },
        "text": "help",
        "normalized": "help"
      }
    },
    {
      "subject": {
        "text": "Anne Le Grand, Vice President of Imaging at Watson Health"
      },
      "sentence": " We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,” said Anne Le Grand, Vice President of Imaging at Watson Health.",
      "object": {
        "text": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally"
      },
      "action": {
        "verb": {
          "text": "say",
          "tense": "past"
        },
        "text": "said",
        "normalized": "say"
      }
    },
    {
      "subject": {
        "text": "by IBM Watson image analytics"
      },
      "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
      "object": {
        "text": "support tools"
      },
      "action": {
        "verb": {
          "text": "power",
          "tense": "past"
        },
        "text": "powered",
        "normalized": "power"
      }
    },
    {
      "subject": {
        "text": "radiologists"
      },
      "sentence": " Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists’ diagnostic decisions for their patients.",
      "object": {
        "text": "diagnostic decisions for their patients"
      },
      "action": {
        "verb": {
          "text": "inform",
          "tense": "future"
        },
        "text": "designed to inform",
        "normalized": "design to inform"
      }
    },
    {
      "subject": {
        "text": "These offerings"
      },
      "sentence": " These offerings are being developed with a shared objective to create insights derived from IBM Watson image analytics to help inform clinical decisions.",
      "object": {
        "text": "insights derived from IBM Watson image analytics to help inform clinical decisions"
      },
      "action": {
        "verb": {
          "text": "create",
          "tense": "future"
        },
        "text": "to create",
        "normalized": "to create"
      }
    },
    {
      "subject": {
        "text": "We"
      },
      "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
      "object": {
        "text": "to working with IBM Watson Health"
      },
      "action": {
        "verb": {
          "text": "look",
          "tense": "present"
        },
        "text": "look",
        "normalized": "look"
      }
    },
    {
      "subject": {
        "text": "first project"
      },
      "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
      "object": {
        "text": "at better assisting radiologists with augmented intelligence"
      },
      "action": {
        "verb": {
          "text": "aim",
          "tense": "past"
        },
        "text": "aimed",
        "normalized": "aim"
      }
    },
    {
      "subject": {
        "text": "radiologists"
      },
      "sentence": " “We look forward to working with IBM Watson Health on Guerbet’s first project aimed at better assisting radiologists with augmented intelligence.",
      "object": {
        "text": "with augmented intelligence"
      },
      "action": {
        "verb": {
          "text": "assist",
          "tense": "present"
        },
        "text": "assisting",
        "normalized": "assist"
      }
    },
    {
      "subject": {
        "text": "This"
      },
      "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
      "object": {
        "text": "us grow our capabilities"
      },
      "action": {
        "verb": {
          "text": "help",
          "tense": "future"
        },
        "text": "will help",
        "normalized": "will help"
      }
    },
    {
      "subject": {
        "text": "François Nicolas, Chief Digital Officer at Guerbet"
      },
      "sentence": " This will help us grow our capabilities in AI to enable innovative solutions improving care pathways.” said François Nicolas, Chief Digital Officer at Guerbet.",
      "object": {
        "text": "This will help us grow our capabilities in AI to enable innovative solutions improving care pathways."
      },
      "action": {
        "verb": {
          "text": "say",
          "tense": "past"
        },
        "text": "said",
        "normalized": "say"
      }
    },
    {
      "subject": {
        "text": "Guerbet"
      },
      "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
      "object": {
        "text": "a pioneer in the contrast-agent field"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "is",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "Guerbet"
      },
      "sentence": " Guerbet is a pioneer in the contrast-agent field, with more than 90 years’ experience, and is a leader in medical imaging worldwide.",
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "is",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "It"
      },
      "sentence": " It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.",
      "object": {
        "text": "a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients"
      },
      "action": {
        "verb": {
          "text": "offer",
          "tense": "present"
        },
        "text": "offers",
        "normalized": "offer"
      }
    },
    {
      "subject": {
        "text": "8% of revenue"
      },
      "sentence": " With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
      "object": {
        "text": "to R&D and more than 200 employees"
      },
      "action": {
        "verb": {
          "text": "dedicate",
          "tense": "past"
        },
        "text": "dedicated",
        "normalized": "dedicate"
      }
    },
    {
      "subject": {
        "text": "Guerbet (GBT)"
      },
      "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
      "object": {
        "text": "on Euronext Paris (segment B – mid caps)"
      },
      "action": {
        "verb": {
          "text": "list",
          "tense": "past"
        },
        "text": "is listed",
        "normalized": "be list"
      }
    },
    {
      "subject": {
        "text": "Guerbet (GBT)"
      },
      "sentence": " Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.",
      "object": {
        "text": "€807 million in revenue"
      },
      "action": {
        "verb": {
          "text": "generate",
          "tense": "past"
        },
        "text": "generated",
        "normalized": "generate"
      }
    },
    {
      "subject": {
        "text": "Watson Health"
      },
      "sentence": " Watson Health is a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health.",
      "object": {
        "text": "a business unit of IBM that is dedicated to the development and implementation of AI and data-driven technologies to advance health"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "is",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "Watson Health technologies"
      },
      "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
      "object": {
        "text": "tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
      },
      "action": {
        "verb": {
          "text": "be",
          "tense": "present"
        },
        "text": "are",
        "normalized": "be"
      }
    },
    {
      "subject": {
        "text": "Watson Health technologies"
      },
      "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
      "object": {
        "text": "a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more"
      },
      "action": {
        "verb": {
          "text": "tackle",
          "tense": "present"
        },
        "text": "are tackling",
        "normalized": "be tackle"
      }
    },
    {
      "subject": {
        "text": "cancer, diabetes, drug discovery and more"
      },
      "sentence": " Watson Health technologies are tackling a wide range of the world’s biggest healthcare challenges including cancer, diabetes, drug discovery and more.",
      "object": {
        "text": "a wide range of the world’s biggest healthcare challenges"
      },
      "action": {
        "verb": {
          "text": "include",
          "tense": "present"
        },
        "text": "including",
        "normalized": "include"
      }
    },
    {
      "subject": {
        "text": "more"
      },
      "sentence": " Learn more at ibm.com/watson/health ",
      "object": {
        "text": "at ibm.com/watson/health"
      },
      "action": {
        "verb": {
          "text": "Learn",
          "tense": "present"
        },
        "text": "Learn",
        "normalized": "Learn"
      }
    }
  ],
  "retrieved_url": "https://newsroom.ibm.com/Guerbet-and-IBM-Watson-Health-Announce-Strategic-Partnership-for-Artificial-Intelligence-in-Medical-Imaging-Liver",
  "relations": [
    {
      "type": "locatedAt",
      "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
      "score": 0.672592,
      "arguments": [
        {
          "text": "Cambridge",
          "location": [
            24,
            33
          ],
          "entities": [
            {
              "type": "GeopoliticalEntity",
              "text": "Cambridge"
            }
          ]
        },
        {
          "text": "USA",
          "location": [
            35,
            38
          ],
          "entities": [
            {
              "type": "GeopoliticalEntity",
              "text": "United States",
              "disambiguation": {
                "subtype": [
                  "Country"
                ]
              }
            }
          ]
        }
      ]
    },
    {
      "type": "partOfMany",
      "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
      "score": 0.69467,
      "arguments": [
        {
          "text": "their",
          "location": [
            2251,
            2256
          ],
          "entities": [
            {
              "type": "Person",
              "text": "their"
            }
          ]
        },
        {
          "text": "patients",
          "location": [
            2302,
            2310
          ],
          "entities": [
            {
              "type": "Person",
              "text": "patients"
            }
          ]
        }
      ]
    },
    {
      "type": "partOfMany",
      "sentence": "\"Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients.",
      "score": 0.179295,
      "arguments": [
        {
          "text": "patients",
          "location": [
            2302,
            2310
          ],
          "entities": [
            {
              "type": "Person",
              "text": "patients"
            }
          ]
        },
        {
          "text": "their",
          "location": [
            2296,
            2301
          ],
          "entities": [
            {
              "type": "Person",
              "text": "their"
            }
          ]
        }
      ]
    },
    {
      "type": "hasAttribute",
      "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
      "score": 0.79643,
      "arguments": [
        {
          "text": "Guerbet",
          "location": [
            2393,
            2400
          ],
          "entities": [
            {
              "type": "Person",
              "text": "Guerbet"
            }
          ]
        },
        {
          "text": "liver cancer",
          "location": [
            2492,
            2504
          ],
          "entities": [
            {
              "type": "HealthCondition",
              "text": "liver cancer"
            }
          ]
        }
      ]
    },
    {
      "type": "agentOf",
      "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
      "score": 0.954126,
      "arguments": [
        {
          "text": "Anne Le Grand",
          "location": [
            2521,
            2534
          ],
          "entities": [
            {
              "type": "Person",
              "text": "Anne Le Grand"
            }
          ]
        },
        {
          "text": "said",
          "location": [
            2516,
            2520
          ],
          "entities": [
            {
              "type": "EventCommunication",
              "text": "said"
            }
          ]
        }
      ]
    },
    {
      "type": "managerOf",
      "sentence": "We are excited to bring together the significant respective expertise of IBM and Guerbet to advance innovation in this important field, and ultimately help combat the challenge of liver cancer globally,\" said Anne Le Grand, Vice President of Imaging at Watson Health.",
      "score": 0.570255,
      "arguments": [
        {
          "text": "Vice President of Imaging",
          "location": [
            2536,
            2561
          ],
          "entities": [
            {
              "type": "Person",
              "text": "Anne Le Grand"
            }
          ]
        },
        {
          "text": "Watson Health",
          "location": [
            2565,
            2578
          ],
          "entities": [
            {
              "type": "Organization",
              "text": "Watson Health",
              "disambiguation": {
                "subtype": [
                  "Commercial"
                ]
              }
            }
          ]
        }
      ]
    },
    {
      "type": "partOfMany",
      "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
      "score": 0.548518,
      "arguments": [
        {
          "text": "radiologists",
          "location": [
            2728,
            2740
          ],
          "entities": [
            {
              "type": "Person",
              "text": "radiologists"
            }
          ]
        },
        {
          "text": "patients",
          "location": [
            2773,
            2781
          ],
          "entities": [
            {
              "type": "Person",
              "text": "patients"
            }
          ]
        }
      ]
    },
    {
      "type": "partOfMany",
      "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
      "score": 0.227306,
      "arguments": [
        {
          "text": "patients",
          "location": [
            2773,
            2781
          ],
          "entities": [
            {
              "type": "Person",
              "text": "patients"
            }
          ]
        },
        {
          "text": "their",
          "location": [
            2767,
            2772
          ],
          "entities": [
            {
              "type": "Person",
              "text": "family"
            }
          ]
        }
      ]
    },
    {
      "type": "agentOf",
      "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
      "score": 0.760628,
      "arguments": [
        {
          "text": "François Nicolas",
          "location": [
            3191,
            3207
          ],
          "entities": [
            {
              "type": "Person",
              "text": "François Nicolas"
            }
          ]
        },
        {
          "text": "said",
          "location": [
            3186,
            3190
          ],
          "entities": [
            {
              "type": "EventCommunication",
              "text": "said"
            }
          ]
        }
      ]
    },
    {
      "type": "locatedAt",
      "sentence": "\" said Franæois Nicolas, Chief Digital Officer at Guerbet.",
      "score": 0.542882,
      "arguments": [
        {
          "text": "Chief Digital Officer",
          "location": [
            3209,
            3230
          ],
          "entities": [
            {
              "type": "Person",
              "text": "François Nicolas"
            }
          ]
        },
        {
          "text": "Guerbet",
          "location": [
            3234,
            3241
          ],
          "entities": [
            {
              "type": "GeopoliticalEntity",
              "text": "Guerbet"
            }
          ]
        }
      ]
    },
    {
      "type": "locatedAt",
      "sentence": "With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation.",
      "score": 0.506287,
      "arguments": [
        {
          "text": "employees",
          "location": [
            3614,
            3623
          ],
          "entities": [
            {
              "type": "Person",
              "text": "employees"
            }
          ]
        },
        {
          "text": "France",
          "location": [
            3659,
            3665
          ],
          "entities": [
            {
              "type": "GeopoliticalEntity",
              "text": "France",
              "disambiguation": {
                "subtype": [
                  "Country"
                ]
              }
            }
          ]
        }
      ]
    },
    {
      "type": "timeOf",
      "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
      "score": 0.965172,
      "arguments": [
        {
          "text": "today",
          "location": [
            185,
            190
          ],
          "entities": [
            {
              "type": "Date",
              "text": "today"
            }
          ]
        },
        {
          "text": "announced",
          "location": [
            191,
            200
          ],
          "entities": [
            {
              "type": "EventCommunication",
              "text": "announced"
            }
          ]
        }
      ]
    },
    {
      "type": "partOf",
      "sentence": "Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am CEST) - Guerbet a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive joint development agreement to develop an artificial intelligence (AI) software solution in collaboration with IBM (NYSE: IBM) Watson Health to support liver cancer diagnostics and care utilizing CT and MRI imaging.",
      "score": 0.521439,
      "arguments": [
        {
          "text": "Watson Health",
          "location": [
            360,
            373
          ],
          "entities": [
            {
              "type": "Organization",
              "text": "Watson Health",
              "disambiguation": {
                "subtype": [
                  "Commercial"
                ]
              }
            }
          ]
        },
        {
          "text": "IBM",
          "location": [
            355,
            358
          ],
          "entities": [
            {
              "type": "Organization",
              "text": "IBM Watson Health",
              "disambiguation": {
                "subtype": [
                  "Commercial"
                ]
              }
            }
          ]
        }
      ]
    },
    {
      "type": "managerOf",
      "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
      "score": 0.607758,
      "arguments": [
        {
          "text": "Advisor",
          "location": [
            613,
            620
          ],
          "entities": [
            {
              "type": "Person",
              "text": "Advisor"
            }
          ]
        },
        {
          "text": "Watson Imaging Care",
          "location": [
            593,
            612
          ],
          "entities": [
            {
              "type": "Organization",
              "text": "Watson Imaging Care",
              "disambiguation": {
                "subtype": [
                  "Commercial"
                ]
              }
            }
          ]
        }
      ]
    },
    {
      "type": "managerOf",
      "sentence": "Watson Imaging Care Advisor for Liver will be a part of a family of decision support tools powered by IBM Watson image analytics designed to inform radiologists' diagnostic decisions for their patients.",
      "score": 0.827154,
      "arguments": [
        {
          "text": "Advisor",
          "location": [
            2600,
            2607
          ],
          "entities": [
            {
              "type": "Person",
              "text": "Advisor"
            }
          ]
        },
        {
          "text": "Watson Imaging Care",
          "location": [
            2580,
            2599
          ],
          "entities": [
            {
              "type": "Organization",
              "text": "Watson Imaging Care",
              "disambiguation": {
                "subtype": [
                  "Commercial"
                ]
              }
            }
          ]
        }
      ]
    },
    {
      "type": "hasAttribute",
      "sentence": "The first, called Watson Imaging Care Advisor[1] for Liver, is planned to be a diagnostic support tool that will use artificial intelligence to automate the detection, staging, tracking, monitoring, therapy prediction and therapy response of primary and secondary liver cancer for clinicians.",
      "score": 0.829171,
      "arguments": [
        {
          "text": "clinicians",
          "location": [
            856,
            866
          ],
          "entities": [
            {
              "type": "Person",
              "text": "clinicians"
            }
          ]
        },
        {
          "text": "cancer",
          "location": [
            845,
            851
          ],
          "entities": [
            {
              "type": "HealthCondition",
              "text": "cancers"
            }
          ]
        }
      ]
    },
    {
      "type": "hasAttribute",
      "sentence": "[4] The liver is also a common site for metastases, particularly in the case of digestive cancers, in which nearly 50% of patients develop metastases.",
      "score": 0.750776,
      "arguments": [
        {
          "text": "patients",
          "location": [
            1318,
            1326
          ],
          "entities": [
            {
              "type": "Person",
              "text": "patients"
            }
          ]
        },
        {
          "text": "cancers",
          "location": [
            1286,
            1293
          ],
          "entities": [
            {
              "type": "HealthCondition",
              "text": "cancers"
            }
          ]
        }
      ]
    },
    {
      "type": "agentOf",
      "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
      "score": 0.896574,
      "arguments": [
        {
          "text": "Yves L’Epine",
          "location": [
            1868,
            1880
          ],
          "entities": [
            {
              "type": "Person",
              "text": "Yves L’Epine"
            }
          ]
        },
        {
          "text": "said",
          "location": [
            1863,
            1867
          ],
          "entities": [
            {
              "type": "EventCommunication",
              "text": "said"
            }
          ]
        }
      ]
    },
    {
      "type": "clientOf",
      "sentence": "We are proud to work with IBM Watson Health to develop a solution dedicated to liver disease, which could help make it possible for clinicians to make more informed characterizations of tissue without recourse to biopsy,\" said Yves L'Epine, Guerbet's CEO.",
      "score": 0.409639,
      "arguments": [
        {
          "text": "Guerbet",
          "location": [
            1882,
            1889
          ],
          "entities": [
            {
              "type": "Person",
              "text": "Guerbet"
            }
          ]
        },
        {
          "text": "CEO",
          "location": [
            1892,
            1895
          ],
          "entities": [
            {
              "type": "Person",
              "text": "Yves L’Epine"
            }
          ]
        }
      ]
    },
    {
      "type": "managerOf",
      "sentence": "Care Advisor for Liver will be designed to be compatible with the most common PACS visualization systems, making it easy to be integrated directly into the workflows of healthcare professionals.",
      "score": 0.771235,
      "arguments": [
        {
          "text": "Advisor",
          "location": [
            1902,
            1909
          ],
          "entities": [
            {
              "type": "Person",
              "text": "Advisor"
            }
          ]
        },
        {
          "text": "Care",
          "location": [
            1897,
            1901
          ],
          "entities": [
            {
              "type": "Organization",
              "text": "Watson Imaging Care",
              "disambiguation": {
                "subtype": [
                  "Commercial"
                ]
              }
            }
          ]
        }
      ]
    }
  ],
  "metadata": {
    "title": "Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver",
    "publication_date": "2018-07-10T00:00:00",
    "image": "",
    "feeds": [
      {
        "link": "https://newsroom.ibm.com/announcements?pagetemplate=rss"
      }
    ],
    "authors": []
  },
  "language": "en",
  "keywords": [
    {
      "text": "Watson Health",
      "relevance": 0.716382,
      "count": 3
    },
    {
      "text": "liver cancer diagnostics",
      "relevance": 0.680537,
      "count": 1
    },
    {
      "text": "IBM Watson Health plan",
      "relevance": 0.624009,
      "count": 1
    },
    {
      "text": "artificial intelligence",
      "relevance": 0.616959,
      "count": 3
    },
    {
      "text": "secondary liver cancer",
      "relevance": 0.572779,
      "count": 1
    },
    {
      "text": "interventional medical imaging",
      "relevance": 0.570391,
      "count": 1
    },
    {
      "text": "Liver cancer",
      "relevance": 0.569905,
      "count": 2
    },
    {
      "text": "Watson Imaging Care Advisor",
      "relevance": 0.566132,
      "count": 2
    },
    {
      "text": "IBM Watson image analytics",
      "relevance": 0.565653,
      "count": 2
    },
    {
      "text": "IBM Watson Health",
      "relevance": 0.555159,
      "count": 2
    },
    {
      "text": "clinical decision support solutions",
      "relevance": 0.554027,
      "count": 1
    },
    {
      "text": "important field",
      "relevance": 0.551971,
      "count": 1
    },
    {
      "text": "IBM",
      "relevance": 0.550497,
      "count": 2
    },
    {
      "text": "common site",
      "relevance": 0.543831,
      "count": 1
    },
    {
      "text": "IBM Research team",
      "relevance": 0.54343,
      "count": 1
    },
    {
      "text": "Guerbet’s first project",
      "relevance": 0.543398,
      "count": 1
    },
    {
      "text": "medical imaging",
      "relevance": 0.539507,
      "count": 1
    },
    {
      "text": "diagnostic support tool",
      "relevance": 0.537071,
      "count": 1
    },
    {
      "text": "second leading cause of cancer death",
      "relevance": 0.535483,
      "count": 1
    },
    {
      "text": "Vice President",
      "relevance": 0.534637,
      "count": 1
    },
    {
      "text": "exclusive joint development agreement",
      "relevance": 0.533562,
      "count": 1
    },
    {
      "text": "innovative solutions",
      "relevance": 0.533158,
      "count": 1
    },
    {
      "text": "primary liver cancer cases",
      "relevance": 0.531554,
      "count": 1
    },
    {
      "text": "liver disease",
      "relevance": 0.530825,
      "count": 1
    },
    {
      "text": "Guerbet’s CEO",
      "relevance": 0.530769,
      "count": 1
    },
    {
      "text": "significant respective expertise of IBM",
      "relevance": 0.530481,
      "count": 1
    },
    {
      "text": "therapy prediction",
      "relevance": 0.528744,
      "count": 1
    },
    {
      "text": "medical devices",
      "relevance": 0.528408,
      "count": 1
    },
    {
      "text": "fastest growing cause of cancer deaths",
      "relevance": 0.528181,
      "count": 1
    },
    {
      "text": "United States",
      "relevance": 0.527403,
      "count": 2
    },
    {
      "text": "software solution",
      "relevance": 0.524276,
      "count": 1
    },
    {
      "text": "comprehensive range of pharmaceutical products",
      "relevance": 0.524195,
      "count": 1
    },
    {
      "text": "better characterization",
      "relevance": 0.523019,
      "count": 1
    },
    {
      "text": "informed characterizations of tissue",
      "relevance": 0.520003,
      "count": 1
    },
    {
      "text": "challenge of liver cancer",
      "relevance": 0.519166,
      "count": 1
    },
    {
      "text": "contrast agents",
      "relevance": 0.519015,
      "count": 1
    },
    {
      "text": "solutions",
      "relevance": 0.518529,
      "count": 1
    },
    {
      "text": "drug discovery",
      "relevance": 0.518322,
      "count": 1
    },
    {
      "text": "business unit of IBM",
      "relevance": 0.516144,
      "count": 1
    },
    {
      "text": "part of a family of decision support tools",
      "relevance": 0.514169,
      "count": 1
    },
    {
      "text": "shared objective",
      "relevance": 0.512652,
      "count": 1
    },
    {
      "text": "Anne Le Grand",
      "relevance": 0.512499,
      "count": 1
    },
    {
      "text": "collaboration",
      "relevance": 0.511784,
      "count": 2
    },
    {
      "text": "use",
      "relevance": 0.511673,
      "count": 1
    },
    {
      "text": "Liver",
      "relevance": 0.511563,
      "count": 4
    },
    {
      "text": "care",
      "relevance": 0.511533,
      "count": 1
    },
    {
      "text": "France",
      "relevance": 0.511131,
      "count": 2
    },
    {
      "text": "workflows of healthcare professionals",
      "relevance": 0.510525,
      "count": 1
    },
    {
      "text": "critical area of healthcare",
      "relevance": 0.50995,
      "count": 1
    },
    {
      "text": "offerings",
      "relevance": 0.508136,
      "count": 1
    }
  ],
  "entities": [
    {
      "type": "Organization",
      "text": "Guerbet",
      "relevance": 0.951857,
      "disambiguation": {
        "subtype": [
          "Company"
        ],
        "name": "Guerbet",
        "dbpedia_resource": "http://dbpedia.org/resource/Guerbet"
      },
      "count": 6,
      "confidence": 0.992578
    },
    {
      "type": "Organization",
      "text": "IBM Watson Health",
      "relevance": 0.845477,
      "count": 3,
      "confidence": 0.956563
    },
    {
      "type": "Organization",
      "text": "Watson Health",
      "relevance": 0.713947,
      "count": 4,
      "confidence": 0.994271
    },
    {
      "type": "JobTitle",
      "text": "Watson Imaging Care Advisor",
      "relevance": 0.636466,
      "count": 2,
      "confidence": 0.758272
    },
    {
      "type": "Location",
      "text": "Villepinte (France",
      "relevance": 0.522923,
      "count": 1,
      "confidence": 0.455182
    },
    {
      "type": "JobTitle",
      "text": "global specialist",
      "relevance": 0.51449,
      "count": 1,
      "confidence": 0.898168
    },
    {
      "type": "JobTitle",
      "text": "contrast agents",
      "relevance": 0.512437,
      "count": 1,
      "confidence": 0.513625
    },
    {
      "type": "Organization",
      "text": "IBM",
      "relevance": 0.472816,
      "disambiguation": {
        "subtype": [
          "SoftwareLicense",
          "Company",
          "OperatingSystemDeveloper",
          "ProcessorManufacturer",
          "SoftwareDeveloper",
          "CompanyFounder",
          "ProgrammingLanguageDesigner",
          "ProgrammingLanguageDeveloper"
        ],
        "name": "IBM",
        "dbpedia_resource": "http://dbpedia.org/resource/IBM"
      },
      "count": 4,
      "confidence": 0.999859
    },
    {
      "type": "Organization",
      "text": "IBM Watson",
      "relevance": 0.390354,
      "count": 2,
      "confidence": 0.777948
    },
    {
      "type": "Person",
      "text": "Yves L’Epine",
      "relevance": 0.318308,
      "count": 1,
      "confidence": 0.338964
    },
    {
      "type": "Organization",
      "text": "Guerbet’s CEO",
      "relevance": 0.316591,
      "count": 1,
      "confidence": 0.272542
    },
    {
      "type": "JobTitle",
      "text": "Care Advisor",
      "relevance": 0.314872,
      "count": 1,
      "confidence": 0.923817
    },
    {
      "type": "Organization",
      "text": "IBM Research",
      "relevance": 0.28884,
      "count": 1,
      "confidence": 0.854673
    },
    {
      "type": "Person",
      "text": "Anne Le Grand",
      "relevance": 0.238705,
      "count": 1,
      "confidence": 0.584993
    },
    {
      "type": "JobTitle",
      "text": "Vice President of Imaging",
      "relevance": 0.236068,
      "count": 1,
      "confidence": 0.492345
    },
    {
      "type": "Organization",
      "text": "NYSE",
      "relevance": 0.235366,
      "disambiguation": {
        "subtype": [
          "Location",
          "Company",
          "Facility",
          "HistoricPlace",
          "Building"
        ],
        "name": "New_York_Stock_Exchange",
        "dbpedia_resource": "http://dbpedia.org/resource/New_York_Stock_Exchange"
      },
      "count": 1,
      "confidence": 0.934449
    },
    {
      "type": "Organization",
      "text": "MRI",
      "relevance": 0.232688,
      "count": 1,
      "confidence": 0.682634
    },
    {
      "type": "Location",
      "text": "Cambridge",
      "relevance": 0.227427,
      "count": 1,
      "confidence": 0.867439
    },
    {
      "type": "JobTitle",
      "text": "radiologists",
      "relevance": 0.205876,
      "count": 2,
      "confidence": 0.85016
    },
    {
      "type": "Location",
      "text": "USA",
      "relevance": 0.18222,
      "disambiguation": {
        "subtype": [
          "HumanLanguage",
          "PoliticalDistrict",
          "Region",
          "AdministrativeDivision",
          "Country",
          "GovernmentalJurisdiction"
        ],
        "name": "Italy",
        "dbpedia_resource": "http://dbpedia.org/resource/Italy"
      },
      "count": 1,
      "confidence": 0.496166
    },
    {
      "type": "JobTitle",
      "text": "clinicians",
      "relevance": 0.162803,
      "count": 1,
      "confidence": 0.672112
    },
    {
      "type": "Person",
      "text": "François Nicolas",
      "relevance": 0.151782,
      "count": 1,
      "confidence": 0.984179
    },
    {
      "type": "JobTitle",
      "text": "Chief Digital Officer",
      "relevance": 0.149039,
      "count": 1,
      "confidence": 0.844456
    },
    {
      "type": "Location",
      "text": "United States",
      "relevance": 0.148527,
      "disambiguation": {
        "subtype": [
          "Region",
          "AdministrativeDivision",
          "Country",
          "GovernmentalJurisdiction",
          "FilmEditor"
        ],
        "name": "United_States",
        "dbpedia_resource": "http://dbpedia.org/resource/United_States"
      },
      "count": 2,
      "confidence": 0.99803
    },
    {
      "type": "Person",
      "text": "Guerbet",
      "relevance": 0.145419,
      "count": 1,
      "confidence": 0.482155
    },
    {
      "type": "JobTitle",
      "text": "physician",
      "relevance": 0.107807,
      "count": 1,
      "confidence": 0.883194
    },
    {
      "type": "Organization",
      "text": "R&D",
      "relevance": 0.098017,
      "disambiguation": {
        "subtype": [
          "Industry"
        ],
        "name": "Research_and_development",
        "dbpedia_resource": "http://dbpedia.org/resource/Research_and_development"
      },
      "count": 1,
      "confidence": 0.873433
    },
    {
      "type": "Organization",
      "text": "Guerbet (GBT",
      "relevance": 0.073968,
      "count": 1,
      "confidence": 0.308671
    },
    {
      "type": "Organization",
      "text": "Euronext Paris",
      "relevance": 0.048738,
      "count": 1,
      "confidence": 0.350544
    },
    {
      "type": "Location",
      "text": "France",
      "relevance": 0.02958,
      "disambiguation": {
        "subtype": [
          "Region",
          "AdministrativeDivision",
          "Country",
          "GovernmentalJurisdiction",
          "FilmDirector"
        ],
        "name": "France",
        "dbpedia_resource": "http://dbpedia.org/resource/France"
      },
      "count": 1,
      "confidence": 0.998555
    },
    {
      "type": "Location",
      "text": "Israel",
      "relevance": 0.028307,
      "disambiguation": {
        "subtype": [
          "Country",
          "GovernmentalJurisdiction",
          "FilmArtDirector"
        ],
        "name": "Israel",
        "dbpedia_resource": "http://dbpedia.org/resource/Israel"
      },
      "count": 1,
      "confidence": 0.920981
    }
  ],
  "emotion": {
    "document": {
      "emotion": {
        "sadness": 0.154,
        "joy": 0.580866,
        "fear": 0.064083,
        "disgust": 0.036787,
        "anger": 0.042247
      }
    }
  },
  "concepts": [
    {
      "text": "Cancer",
      "relevance": 0.956922,
      "dbpedia_resource": "http://dbpedia.org/resource/Cancer"
    },
    {
      "text": "Health care",
      "relevance": 0.82318,
      "dbpedia_resource": "http://dbpedia.org/resource/Health_care"
    },
    {
      "text": "Magnetic resonance imaging",
      "relevance": 0.649831,
      "dbpedia_resource": "http://dbpedia.org/resource/Magnetic_resonance_imaging"
    },
    {
      "text": "Medicine",
      "relevance": 0.625157,
      "dbpedia_resource": "http://dbpedia.org/resource/Medicine"
    },
    {
      "text": "Artificial intelligence",
      "relevance": 0.580927,
      "dbpedia_resource": "http://dbpedia.org/resource/Artificial_intelligence"
    },
    {
      "text": "Oncology",
      "relevance": 0.553219,
      "dbpedia_resource": "http://dbpedia.org/resource/Oncology"
    },
    {
      "text": "Liver",
      "relevance": 0.540594,
      "dbpedia_resource": "http://dbpedia.org/resource/Liver"
    },
    {
      "text": "Hepatocellular carcinoma",
      "relevance": 0.538087,
      "dbpedia_resource": "http://dbpedia.org/resource/Hepatocellular_carcinoma"
    }
  ],
  "categories": [
    {
      "score": 0.952376,
      "label": "/health and fitness"
    },
    {
      "score": 0.943401,
      "label": "/health and fitness/therapy"
    },
    {
      "score": 0.895604,
      "label": "/health and fitness/disease/cancer/brain tumor"
    }
  ]
}






##########
